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Chapter I 
GENERAL INTRODUCTION AND PROBLEM STATEMENT 

INTRODUCTION 
The distinction of alpha- and beta-adrenoceptors by Ahl-
quist (1) in 1948 has led to the development of specific alpha-
and beta-adrenoceptor agonists and antagonists. The latter are 
referred to as alpha- and beta-blockers. The beta-blockers are 
used on a very large scale in the treatment of hypertension, 
angina pectoris and in a variety of other disorders. We would 
like to focus on the beta-blockers as antihypertensive drugs. 
Although they have been used in the treatment of hypertension 
for almost 20 years, their exact mode of action is not yet known. 
In 1967 Lands (2) made a subdivision of beta-adrenoceptors 
in beta-]- and beta2-receptors and subsequently beta-blockers 
with a greater affinity to beta-]-receptors have been developed, 
so-called "cardioselective" beta-blockers. The term cardioselec-
tive or betai-selective contrasts with the beta-blockers that 
have an affinity to both beta·]- and beta2-receptors and that are 
called non-selective beta-blockers. This thesis deals with the 
possible clinical significance of the property: beta--selectivi-
ty, with special emphasis on the peripheral vascular system 
during situations with increased sympatho-adrenal activity. 
Since the introduction of beta-blockers, almost 20 com-
pounds have reached the market. Despite differences in pharmaco-
logical properties as membrane stabilizing activity, intrinsic 
sympathomimetic activity or beta-| -selectivity all beta-blockers 
lower blood pressure equally. It has been postulated therefore 
that the antihypertensive effect of the beta-blockers is due to 
the competitive blockade of the beta-]-receptors (3), but the 
discussion continues concerning the precise mode of action. The 
disposal of more or less selective beta-blockers has made it 
possible to examine the role of the different receptors in va-
rious tissues. 
Although the separation m beta-|- and beta2-receptors is 
not absolute, because most tissues share both receptors, one 
can make an outline of the receptor distribution, that is appli-
cable for practical purposes. As to the cardiovascular system 
the beta-]-receptors are particulary localized in the heart and 
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the beta2-receptors mainly in the blood vessels of skeletal 
muscles. Moreover, in many tissues alpha-receptors are also 
present. So the effect of the natural catecholamines is the 
result of the effects on different receptors. 
The hormone adrenaline will induce both vasodilation (beta2-
receptor stimulation) and vasoconstriction (alpha-receptor sti-
mulation) in blood vessels of skeletal muscles. Normally, the 
net effect is vasodilation suggesting a greater affinity of 
adrenaline for beta2- than for alpha-receptors or a predominance 
of beta2-receptors in the vessels. When the beta-receptors are 
occupied by a non-selective beta-blocker the effect of adrena-
line will be vasoconstriction due to so-called unopposed alpha-
receptor stimulation. That this may have clinical significance 
was suggested by reports in the literature of unexplained short-
time rises in blood pressure during chronic treatment of patients 
with non-selective beta-blockers (4,5). Since in most of these 
situations a stimulation of the sympatho-adrenal system or 
"stress" was present, the above mentioned unopposed alpha-recep-
tor stimulation seemed to give an explanation for this vasocon-
strictive or "pressor" reaction. Going into this question, Johnsson 
(6) investigated the haemodynamic effects of an adrenaline infu-
sion in normotensive subjects, after propranolol (a non-selective 
beta-blocker) or metoprolol (a betai-selective blocker) had been 
given intravenously. Indeed, an impressive difference was ob-
served. Adrenaline infusion after administration of propranolol 
caused an increase of the vascular resistance in the forearm and 
a considerable rise in the systolic and diastolic blood pressure. 
But after metoprolol, adrenaline induced a fall in forearm vascu-
lar resistance, thus a vasodilation, very similar to the normal 
reaction to adrenaline. Apparently the normal vasodilating action 
of adrenaline is made impossible by beta2-blockade, so that 
alpha-mediated vasoconstriction predominates. These findings 
suggest that beta--receptor blockade may have disadvantages. 
However Johnsson (6) studied normotensive subjects after intra-
venous Deta-blockade, so the first step in examining the clini-
cal relevance of these "pressor" responses to adrenaline during 
non-selective beta-blockade was the infusion of adrenaline in 
14 
hypertensive patients, who were treated chronically with non-
selective and beta·] -selective blockers. This study of van Her-
waarden (7) strongly confirmed the findinos of Johnsson 
(6) and in fact formed the starting-point of our studies pre-
sented in this thesis. 
AIM OF THE STUDY 
The first step was to answer the question whether the un-
favourable pressor response still exists, when adrenaline is 
infused during treatment with a combination of a non-selective 
beta-blocker with a vasodilator and/or a diuretic (chapter II). 
These combinations are frequently used in hypertension. More-
over, we went into the question of whether beta-|-selectivity 
is a relative property disappearing at higher plasma levels of 
metoprolol. Further, we assessed plasma levels of adrenaline, 
which were exceptionally high during adrenaline infusion. In 
order to approximate situations of daily life stress, the effects 
of lower doses of adrenaline during non-selective and beta·]-
selective blockade were also evaluated (chapter III). 
Admittedly, daily life stresses involve more complicated 
processes than does the infusion of adrenaline. The main object 
of our study, therefore, evolved into finding out whether treat-
ment with beta·]-selective or non-selective beta-blockade results 
in varying haemodynamic effects during physiological states of 
raised sympatho-adrenal activity. Examples of states with raised 
sympatho-adrenal activity or daily life stresses are: environ-
mental stress such as cold exposure, pharmacological stresses 
such as the drinking of coffee and the smoking of cigarettes, 
mental stress (mental antnmetic) and finally physical exertion 
such as isometric and dynamic exercise. In order to avoid emo-
tionally stressing stimuli while studying the hemodynamic effects 
of the various stresses we have only used non-invasive measuring 
procedures. In all studies the same haemodynamic parameters were 
measured: blood pressure, heart rate and forearm blood flow. 
Acute cold exposure is a frequently used example of daily 
life stress. In chapter IV a study in normotensive subjects is 
presented concerning the haemodynamic effects of a "cold pressor" 
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test before and after the two kinds of beta-blockade. 
Caffeine and nicotine may be considered as the most frequent­
ly used "drugs" in daily life. Both cause a substantial rise in 
plasma adrenaline (8,9). The results of coffee drinking on haemo-
dynamics and catecholamines in normotensives without previous 
medication and after beta-blockade with propranolol and metopro-
lol are given in chapter V. In chapter VI a study is presented 
of haemodynamic changes in habitual smokers with hypertension 
during treatment with beta.-selective and non-selective beta-
blocking drugs. 
The effects of dynamic exercise during treatment with the 
two beta-blockers were earlier reported by van Herwaarden (10). 
Based on preliminary studies of various stress tests, we 
selected two tests for further study in hypertensive patients: 
mental arithmetic (a derived form of mental stress) and isometric 
exercise. These stresses frequently occur in daily life. Both 
stimuli induce a release of adrenaline (11,12), moreover both 
tests are accompanied by an increase in the blood flow in non-
active muscles (13,14). In these respects mental arithmetic and 
isometric exercise resemble adrenaline infusion. In chapter VII 
A a description is given of haemodynamic characteristics 
and the reproducibility of these two stress tests. Further, we 
assessed the changes in plasma catecholamines induced by both 
tests m normotensive volunteers. Finally, we have examined the 
influence of beta-) -selective and non-selective beta-blockade 
on the haemodynamic response to mental arithmetic and isometric 
exercise in a double blind cross-over trial in hypertensive 
patients (chapter VII В). 
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CHAPTER II 
INFLUENCE OF SELECTIVE AND NON-SELECTIVE BETA-ADRENOCEPTOR 
BLOCKADE ON THE HAEMODYNAMIC EFFECT OF ADRENALINE DURING 
COMBINED ANTIHYPERTENSIVE DRUG THERAPY 
This study was published in part: 
H Houben, Th Thien, Th de Boo, W Lemmens, CLA van Herwaarden, 
JFM Fennis, A van 't Laar 
Clinical Science 57: 397S-399S (1979) 

SUMMARY 
Prompted by the striking differences in haemodynamic reactions 
to adrenaline between propranolol- and metoprolol-treated patients 
we studied the haemodynamic effects of adrenaline during combined 
antihypertensive drug therapy. Twenty-five hypertensive patients 
were successively treated with propranolol and metoprolol. In 12 
patients beta-receptor blockade was combined with diuretics and 
in 13 patients with diuretics and vasodilators. During propranolol 
adrenaline caused a marked pressor effect: there was a consider-
able rise in systolic as well as in diastolic blood pressure and 
a marked fall in heart rate. During metoprolol adrenaline induced 
only a slight rise in blood pressure and an increase in heart rate. 
Forearm blood flow was decreased by adrenaline during propranolol 
and was increased during metoprolol. Calculated vascular resis-
tance showed opposite changes. Results were essentially the same, 
when beta-receptor blockade was combined with diuretics alone or 
with diuretics in combination with vasodilators. Results did not 
differ from previous results obtained in patients treated by beta-
blockade alone, even when strong vasodilators were added to the 
therapeutic regimen. In addition, we found that beta^-selectivity 
decreases at higher plasma levels of the beta-blocker metoprolol. 
It appeared that in our adrenaline experiments plasma-adrenaline 
rose nearly 50-fold, which increase is much larger than in most 
physiological stresses. Although the results of this study also 
argue in favour of beta^-selective blockers, further studies are 
needed with lower-dose adrenaline infusions to approximate adre-
naline levels occurring in stress situations m daily life. 
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INTRODUCTION 
Previous studies (1, 2) showed that infusion of adrenaline 
during treatment with the non-selective beta-blocker propranolol 
has a pronounced pressor effect, probably because the vasodila-
tion mediated by the betaj-receptors is blocked. This pressor 
effect was absent when adrenaline was administered during treat-
ment with the beta., -selective blocker metoprolol. 
In more severe hypertension, however, treatment with beta-
blockers is often combined with diuretics and/or vasodilators (3). 
The question can be raised whether the above mentioned differ-
ence during adrenaline infusion between the two beta-blockers is 
still present after addition of diuretics and/or vasodilators to 
the therapy. From a theoretical point of view diuretics and vaso-
dilators do not act directly via beta-receptors. However, it 
has been shown, that during treatment with diuretics the sensi-
tivity of the beta-receptors diminishes (4). In other studies 
with diuretic agents (5, 6) and a peripheral vasodilator drug 
(7) a significant reduction was demonstrated in the blood pres-
sure response during catecholamine infusion. Therefore, in this 
study we compared the effects of adrenaline infusion during 
propranolol and metoprolol treatment in hypertensive patients, 
who were also treated with diuretics or diuretics and vasodi-
lating drugs. We looked also into the question, whether cardio-
selectivity still exists at high doses of metoprolol. Plasma 
levels of adrenaline were measured in order to compare the 
adrenaline infusion tests with more physiological types of stress. 
PATIENTS AND METHODS 
Twenty-eight hypertensive patients gave their informed consent 
for the study. The results in 3 patients were not used, because 
of poor compliance, as appeared from the plasma levels of the 
beta-blockers. Tables I and II show the clinical data of the 
remaining 25 patients. The patients were divided in two groups, 
12 in group I and 13 in group II. Group I used diuretics beside 
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Table I. Clinical data of the two groups of hypertensive patients 
Number 
male/female 
age (mean + SD) 
weight (mean + SD) 
cause of hypertension 
essential 
renovascular 
left ventricular hypertrophyt 
retinopathy 0 
duration of treatment (months) 
Group I 
(diuretic) 
12 
10/2 
3 7 + 10 
72+12 
12 
0 
0 
29 + 17 
Group II 
(vasodilator) 
13 
8/5 
40 + 6 
73 + 12 
10 
3 
2 
3 (I-III) 
44 + 14 
t electrocardiographic criteria according to Estes (11) 
0
 according to Keith, Wagener and Barker (12) 
the beta-blocking drugs. The medication of group II existed of 
beta-blockers, diuretics and vasodilators. Hypertension in group 
II was more severe and of longer standing than in group I. 
All patients were for at least four weeks on propranolol thera-
py. After the first adrenaline experiment in each patient propra-
nolol was substituted by an equipotent dose of metoprolol: 100 mg 
of metoprolol for each 80 mg of propranolol. The other drugs were 
continued in the same dose. After a period of 1-3 months the 
second test was performed. 
The tests were carried out in a room with a constant tempera-
ture of 20oC, between 09.00 and 12.00 hours, 2-5 hours after 
ingestion of the morning dose. Before the test the patients had 
a light breakfast without coffee and abstained from smoking. 
The test protocol is depicted in figure 1. After 20 m m of 
rest in supine position blood pressure and heart rate were measured 
every 2 min. When five readings had been completed the intravenous 
infusion of adrenaline was started. The infusion rate was stepwise 
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Table II Clinical data of the two groups of hypertensive 
patients 
GROUP I 
(diuretic) 
GROUP II 
(vasodilator) 
blood pressure before 
treatment (mm Hg)* 
(nean ± SEM) 
blood pressure during 
treatment (mm Hg)** 
(mean ± SEM) 
beta-blockers (mean dose and range) 
propranolol (n=12) 
metoprolol (n=12) 
diuretics (mean dose and range) 
chlorthalidone (n=12) 
furosemide (n= 0) 
potassium sparing (n= 2) 
vasodilators (nean dose and range) 
hydralazine 
diazoxide 
177+9 
112±4 
145±4 
97±2 
233(160-320) 
292(200-400) 
73 ( 25-100) (n=10) 
(n= 1) 
(n= 4) 
190+9 
119±5 
141+3 
92±1 
(n=13) 283(160-480) 
(n=13) 354(200-600) 
85 ( 50-100) 
(n=10) 131( 30-200) 
(n= 3) (100-300) 
* mean of measurements during three visits to the outpatient clinic 
before therapy started 
** mean of measurements during last three visits before the infusion 
experiments 
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Figure 1. Schedule of the adrenaline infusion test. 
increased to 8 pg/inin in 4 minutes and then this dose was sus­
tained for 6 minutes. The last two readings during infusion were 
used for statistical analysis. Forearm blood flow was measured 
on the average 9 times before and during the highest dose of 
adrenaline and after stopping the infusion. Blood pressure and 
forearm blood flow were measured at the right arm and this arm 
was elevated obliquely in an arm support about 10 cm above heart 
level. Immediately after the patient had taken the recumbent 
position, a catheter was inserted in a left antecubital vein. 
Blood pressure was measured with a semi-automatic device 
(Arteriosonde 1217), heart rate by ECG and forearm blood flow 
using a mercury strain-gauge venous occlusion Plethysmograph (8). 
Mean arterial pressure (MAP) was calculated as the sum of the 
diastolic and 1/3 of the pulse pressure. Forearm vascular resis­
tance (FVR) was calculated by dividing mean arterial pressure by 
forearm blood flow and expressed in arbitrary units. 
Before the experiment blood was drawn for determination of the 
beta-blockers to check compliance. Drug determination was performe 
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in 28 experiments, 13 times during propranolol treatment and 15 
times during metoprolol treatment. The beta-blocker levels were 
determined using a gas chromatographic method (9). In 26 studies 
blood samples were taken for determination of plasma adrenaline 
and noradrenaline, just before and at the end of the infusion 
(12 times on propranolol and 14 times on metoprolol). Plasma 
adrenaline and noradrenaline were determined with a radio-enzyma-
tic assay (10). 
Statistical analysis 
All measurements before adrenaline infusion and the last two 
readings during infusion were used for statistical analysis. 
For each group and each variable a two-way analysis-of-varlance 
model (fixed effects, inequal cell frequencies) was postulated, 
the first factor being "patient" and the second the "periods of 
measurement" (before, during and after propranolol or metoprolol). 
Estimates of m a m effects and their standard errors were computed 
accordingly. Multiple comparisons were carried out with Scheffé's 
S-method (13). In each analysis both factors and their interaction 
contributed highly significantly (p < 0.001) to the explanation 
of variance implying a rather large variation in reaction between 
patients. 
Plasma levels of the beta-blockers and the levels of plasma 
adrenaline and noradrenaline before and at the end of the in-
fusion were compared with the Student-t-test for paired observa-
tions. A p-value of < 0.05 was considered as the level of signifi-
cance. Correlation coefficients were calculated according to 
Pearson. 
RESULTS 
Figure 2 gives a representative example of the haemodynamic 
changes induced by adrenaline infusion during treatment with 
propranolol and metoprolol respectively. In this example the 
difference in haemodynamic reaction to adrenaline is clearly demon-
strated: vasoconstriction during therapy with propranolol and 
vasodilation during treatment with metoprolol. 
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Figure 2. Ä r ep re sen t a t i ve example of haemodynamic effects of adrenal ine on 
blood pressure (BP), hea r t r a t e (HR), forearm blood flow and fore-
arm vascular r e s i s t a n c e (FVR) in one p a t i e n t on propranolol ( l e f t 
panel) and on metoprolol ( r igh t pane l ) . 
B e s i d e s , t h i s f i g u r e i s an e x a m p l e of t h e haemodynamic 
r e c o r d i n g s i n o u r i n f u s i o n e x p e r i m e n t s . I n f i g u r e 3 t h e r e g i s t r a -
t i o n s a r e d e p i c t e d i n a p a t i e n t , who d i d n o t u s e t h e p r e s c r i b e d 
b e t a - b l o c k e r m e d i c a t i o n , t h u s d e m o n s t r a t i n g t h e n o r m a l r e a c t i o n 
t o a d r e n a l i n e i n f u s i o n . 
B a s a l v a l u e s and t h e haemodynamic e f f e c t s of a d r e n a l i n e i n -
f u s i o n a r e p r e s e n t e d i n t a b l e I I I . I n i t i a l v a l u e s i n b o t h t r e a t -
ment p e r i o d s w e r e n o t s i g n i f i c a n t l y d i f f e r e n t f rom e a c h o t h e r . 
I t s h o u l d b e n o t e d t h a t b l o o d p r e s s u r e v a l u e s b e f o r e t h e s t a r t 
of t h e a d r e n a l i n e i n f u s i o n w e r e l o w e r t h a n t h e v a l u e s d u r i n g 
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treatment, noted at outpatient clinic visits, both because an 
automatic device (Arteriosonde) was used and because the arm was 
elevated above heart level. 
In both treatment periods haemodynamic changes in the diuretic 
group (I) as well as in the vasodilator group (II) were essential-
ly the same, although more pronounced in the diuretic group. 
Therefore the results of only group I will be described. During 
treatment with propranolol adrenaline caused a marked rise of 
systolic (30 mmHg) and diastolic pressure (26 mmHg). The average 
fall in heart rate was 11 beats/min (lowest heart rate recorded: 
(J 020520 
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Figure 3. Example of haemodynamic effects of adrenaline infusion in one patient 
with poor compliance, confirmed by the plasma level of the beta-
blocker (the patient was withdrawn from the study). 
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Table III Hemodynamic effects of adrenaline infusion during propranolol and netoprolol in 2 groups 
of hypertensive patients (see text). Mean values and SE are given before, during and after 
adrenaline. Pi indicates difference betveen "before" and "during". P2 indicates difference 
between propranolol and metoprolol periods during adrenaline. 
* indicates ρ < 0.001. NS = ρ > 0.05. 
Group I (diuretic) 
blood pressure (ram Hg) 
systolic 
diastolic 
mean 
heart rate (beats/min) 
blood flow (ml/I00 ml.mm) 
vascular resistance (U) 
Group II (vasodilator) 
blood pressure (mm Hg) 
systolic 
diastolic 
mean 
heart rate (beats/mm) 
blood flow (ml/100 ml.nun) 
vascular resistance (U) 
PROPRANOLOL 
before 
125 
86 
99 
55 
3.9 
38 
124 
83 
97 
58 
3.7 
34 
+ 
+ 
+ 
± 
± 
+ 
+ 
+ 
+ 
+ 
+ 
± 
0.7 
0.5 
0.4 
0.3 
0.1 
1.8 
П.6 
0.4 
0.3 
0.2 
0.1 
0.9 
during 
155 
112 
127 
44 
3.0 
67 
157 
100 
119 
46 
2.9 
52 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
1.1 
0.7 
0.6 
0.6 
0.1 
1.8 
1.0 
0.7 
0.6 
0.4 
0.1 
0.9 
aftpr 
122 
84 
97 
58 
4.3 
34 
122 
81 
95 
61 
3.7 
33 
+ 
+ 
± 
+ 
+ 
± 
+ 
+ 
+ 
± 
+ 
+ 
1.1 
0.7 
0.6 
0.6 
0.1 
1.8 
0.9 
0.7 
0.5 
0.4 
0.1 
0.8 
P1 
* 
* 
* 
it 
It 
* 
* 
* 
* 
* 
* 
* 
MEHOPROLOL 
before 
124 
85 
98 
54 
2.9 
43 
125 
81 
96 
56 
4.Π 
29 
+ 
+ 
+ 
+ 
+ 
+ 
± 
+ 
± 
+ 
+ 
+ 
0.7 
0.5 
0.4 
0.3 
0.1 
1.7 
0.6 
0.4 
0.3 
0.2 
0.1 
0.9 
during 
135 
86 
102 
61 
4.8 
25 
134 
82 
99 
60 
4.5 
28 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
± 
+ 
± 
1.0 
0.7 
0.6 
0.5 
0.1 
1.7 
0.9 
0.7 
0.5 
0.4 
0.1 
0.8 
after 
125 
82 
96 
58 
2.9 
40 
121 
77 
91 
60 
4.2 
28 
± 
± 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
1.0 
0.7 
0.6 
0.5 
0.1 
1.7 
0.9 
0.7 
0.5 
0.4 
0.1 
0.8 
p1 
* 
N.S 
* 
* 
* 
* 
* 
* 
* 
* 
* 
N.S 
P2 
* 
* 
* 
* 
* 
* 
* 
* 
* 
* 
* 
* 
29 beats/min). Forearm blood flow decreased. Calculated forearm 
vascular resistance showed of course opposite effects, thus a 
sharp rise. During metoprolol treatment adrenaline caused only 
a slight rise in systolic pressure (11 mm Hg) and had no demon-
strable effect on diastolic pressure. Heart rate and forearm 
blood flow increased and forearm vascular resistance decreased. 
In all patients the effect of adrenaline had disappeared within 
4 m m after discontinuation of the infusion. 
The changes in relation to the initial values are represented 
graphically in figure 4. The haemodynamic changes, which occurred 
during interaction of adrenaline with propranolol and with meto-
prolol, showed significant differences. During interaction of 
adrenaline with metoprolol, the systolic and diastolic pressures 
and the MAP were lower than during interaction with propranolol 
(p < 0.001). The bradycardia, induced by adrenaline during pro-
pranolol medication, was absent during treatment with metoprolol 
(p < 0.001). During infusion of adrenaline, the forearm blood 
flow was higher (p < 0.001) and the forearm vascular resistance 
lower (p < 0.001) on metoprolol than on propranolol. 
In the propranolol period during adrenaline infusion complaints 
of pressing sensations on the chest (without changes on ECG), 
signs of cold acra and pallor manifested more frequently (20 pa-
tients) and more extensively on propranolol than in the meto-
prolol period (12 patients). In all cases immediately after 
stopping of the adrenaline infusion the complaints disappeared. 
In 28 studies plasma levels of the beta-blocking drugs were 
determined (figure 5), 13 times of propranolol: 821+184 nmol/1 
(mean + SEM), 15 times of metoprolol: 1109+179 nmol/1 (mean + SEM). 
At low doses, i.e. 240 mg propranolol or less or 300 mg meto-
prolol or less the mean of 16 determinations amounted to 539+102 
(SEM) nmol/1, at the higher dose the level amounted to 1560+150 
(SEM) nmol/l (p < 0.01) (figure 5). 
In group II in 12 patients metoprolol levels were determined 
before the infusion experiments. Figure 6 gives the correlation 
between the change in MAP induced by adrenaline infusion and the 
plasma level of metoprolol. The higher the metoprolol level, the 
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Figure 4. Changes in blood pressure, heart rate, forearm blood flow, and fore­
arm vascular resistance induced by adrenaline infusion after long-term 
treatment with both beta-blockers in two groups of hypertensive patients. 
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Figure 5. Plasma levels of the beta-blockers determined in 28 studies. Low dose 
indicates 240 mg of propranolol or 300 mg of metoprolol or less. 
l a r g e r t h e i n c r e a s e i n MAP (r = 0 . 7 5 ) . Thi s was a l s o t h e c a s e , 
for s y s t o l i c (r = 0.59) and d i a s t o l i c p r e s s u r e (r = 0 . 6 9 ) , but 
n o t f o r h e a r t r a t e or forearm blood flow. However in each p a t i e n t , 
even w i t h a h igh plasma l e v e l of m e t o p r o l o l , as i l l u s t r a t e d i n 
f i g u r e 7, haemodynamic changes on m e t o p r o l o l were more f a v o u r a b l e 
than on p r o p r a n o l o l . 
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Figure 6. Correlation between change in MAP induced by adrenaline and in plas­
ma level of the beta-blocker metoprolol in 12 patients of group II 
during treatment with metoprolol. 
It has been reported that infusion with high doses of adrena­
line can lead to vasoconstriction in the blood vessels of the 
forearm, while infusion with small doses of adrenaline always 
leads to vasodilation (14). Figure 8 shows that even in a patient 
with a high adrenaline level on metoprolol vasodilation occurred, 
whereas even in a patient with a low adrenaline level on propra­
nolol vasoconstriction was seen. 
The adrenaline infusion caused a large rise of the plasma 
adrenaline level. Plasma adrenaline before the infusion amounted 
to 0.52 + 0.19 nmol/l (mean + SEM), at the end of the infusion 
25.0 + 4.65 nmol/l (mean + SEM). Plasma noradrenaline did not 
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change significantly during the infusion of adrenaline; before 
infusion 2.90 + 0.28 nmol/1, after infusion 3.20 + 0.29 nmol/1 
(mean + SEM). 
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Figure 7. Example of haemodynamic effects in one patient before, during and 
after adrenaline infusion on propranolol (left panel) and on meto­
prolol at a high plasma level of the beta.-selective blocker (right 
panel). 
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Figure 8. Example of haemodynamic e f fec t s of adrenal ine infusion in two p a t i e n t s . 
In one p a t i e n t on propranolol a low plasma adrenal ine leve l was 
measured ( l e f t p a n e l ) . In the other p a t i e n t on metoproiol a high 
leve l of plasma adrenal ine was measured ( r i g h t p a n e l ) . 
DISCUSSION 
I n p r e v i o u s s t u d i e s g r e a t d i f f e r e n c e s w e r e f o u n d i n t h e h a e m o -
d y n a m i c e f f e c t s of a n a d r e n a l i n e i n f u s i o n b e t w e e n p r o p r a n o l o l -
a n d m e t o p r o l o l - t r e a t e d s u b j e c t s ( 1 , 2 ) . T h e s e d i f f e r e n c e s a r e a 
c o n s e q u e n c e of t h e f a c t t h a t p r o p r a n o l o l b l o c k s b o t h t h e b e t a , -
a n d b e t a 2 - r e c e p t o r s , t h e r e b y l e a v i n g a d o m i n a t i n g r o l e f o r a l p h a -
r e c e p t o r s t i m u l a t i o n , w h e r e a s d u r i n g m e t o p r o i o l t r e a t m e n t o n l y 
b e t a , - b l o c k a d e t a k e s p l a c e and b e t a 2 - r e c e p t o r s t i m u l a t i o n r e m a i n s 
3 5 
possible. So, during metoprolol the administration of adrenaline 
tends to decrease forearm vascular resistance, whereas during 
propranolol vascular resistance increases considerably. This in-
crease in resistance leads to a further rise in blood pressure. 
Bradycardia develops due to the stimulation of the baroreceptors. 
As mentioned earlier, in more severe hypertension, however, 
treatment with a combination of beta-blockers, diuretics and/or 
vasodilators is usual. Sofar, it had not been investigated, 
whether these differences in adrenaline induced changes between 
beta^-selective and non-selective beta-blockade still hold during 
treatment with these combinations. 
The results of the present study appear to be in full agree-
ment with the previous ones in subjects treated with beta-blocking 
agents only. These findings tend to strengthen the clinical sig-
nificance of the earlier reports, because it now may be supposed 
that adrenaline release during stressful conditions in daily 
life may cause strong and possibly harmful blood pressure rises 
in patients treated with non-selective beta-blockers, even when 
these are combined with strong vasodilating drugs. We did not 
compare the results of adrenaline infusion m both groups of 
patients, because there were many differences between the groups, 
such as a longer history and subsequent treatment in the second 
group. Eventually smaller changes in the vasodilator group (fi-
gure 4) could be explained by a lesser capacity of the vessels 
to react as well as by the treatment with the vasodilating drugs 
(7). However, it seems more important that in both groups the 
haemodynamic changes were essentially in the same direction. 
The correlation between the increase in MAP and the plasma 
level of metoprolol indicates that at higher metoprolol levels 
selectivity decreases, at least concerning the peripheral vaso-
dilator effects. Until now no clinical dose-response studies 
have been reported in hypertensive patients about selectivity of 
the nowadays available selective beta-blockers regarding the vas-
cular beta2-receptors. Our findings are in concordance with other 
studies, which deal with dose and selectivity as shown by an 
effect on beta2-receptors in bronchi (15, 16) and lymphocytes 
(17) or on vascular receptors in peripheral blood vessels as 
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demonstrated for practolol (18) and for metoprolol in normal 
subjects (19). 
The mean increase plasma adrenaline during infusion was nearly 
50-fold. However, such rises are not surprising. Since in other 
studies with lower infusion-rates like 5- and 6 pg/min 20 to 35-
fold increases in plasma adrenaline have been observed (20, 21). 
Recently Cryer et al (22) published plasma adrenaline levels 
during physiological conditions. From this study it appears that 
most physiological stresses are attended with much smaller rises 
in plasma adrenaline. 
The conclusion of our study is that beta^-selective blockers 
should be preferred in conditions with high adrenaline release, 
e.g. hypoglycemia (22), even when diuretics and vasodilators are 
added to the therapy. Further studies of lower-dose adrenaline 
infusion have to be done to extend the conclusions to other 
stresses accompanied by more modest adrenaline release. 
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CHAPTER III 
EFFECT OF LOW-DOSE EPINEPHRINE INFUSION ON HEMODYNAMICS 
AFTER SELECTIVE AND NON-SELECTIVE BETA-BLOCKADE IN 
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SUMMARY 
We studied hemodynamic effects of low doses of epinephrine 
in five hypertensive patients receiving long-term treatment 
with propranolol and metoprolol. Epinephrine was infused at 
graded rates of 0.5, 1.0, 2.0 and 4.0 pg/min. During propranolol 
treatment epinephrine induced a marked pressor effect at all 
rates. There was a considerable rise in systolic as well as in 
diastolic blood pressure and heart rate fell. During metoprolol 
treatment there was only a slight rise in blood pressure and 
heart rate rose. Forearm blood flow was decreased by epinephrine 
during propranolol. Calculated forearm vascular resistance 
showed opposite effects. We conclude that infusion of small 
doses of epinephrine results in a marked difference in reaction 
in propranolol- and metoprolol-treated patients and that this 
may have revelance in the choice of beta-blocker to be used in 
the treatment of hypertension. 
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INTRODUCTION 
We have reported a marked difference in hemodynamic reac-
tion to epinephrine infusion during treatment of hypertensive 
patients with propranolol and metoprolol (8, 9). During treat-
ment with propranolol there was an unfavourable pressor response. 
Mean arterial pressure rose and heart rate and forearm blood 
flow fell; consequently, the calculated forearm vascular resis-
tance rose. During metoprolol treatment the normal reaction to 
epinephrine was unchanged. Epinephrine had been infused at a 
rate of 8 yg/min, however, and this led to a mean 50-fold rise 
in plasma epinephrine. The purpose of our present study was to 
determine whether the difference m hemodynamic reaction also 
persisted during smaller epinephrine infusions (0.5 to 4.0 pg/ 
min) and, if so, at which infusion rate or plasma level of 
epinephrine the difference could be observed. 
PATIENTS AND METHODS 
Our subjects were five hypertensive patients; their clini-
cal data are listed in table 1. All patients were taking either 
long-term propranolol or long-term metoprolol. Three patients 
used chlorthalidone in addition. All had long-standing hyper-
tension; in four it was essential and in one renovascular. 
After the first epinephrine experiment the patients were 
switched to the other beta-blocker. After at least 4 weeks the 
second test was performed. In two patients the propranolol study 
preceded the metoprolol study. A dose of 100 mg metoprolol was 
considered equipotent to 80 mg of propranolol. The drugs were 
given in two or three daily doses. Tests were carried out in 
the morning, 2 h after dose, in a room with a constant tempera-
ture of 19 C. The patients were asked to eat a light breakfast 
and to abstain from smoking and coffee that morning. 
After 20 min in the supine position blood pressure and 
heart rate were measured every 2 min for 10 min. Forearm blood 
flow was measured twice and each measurement is the average of 
five determinations. Then, through a catheter that had been 
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Table 1. Clinical data of the five hypertensive patients 
Men/women 4/1 
Age (yr) (mean and range) 37.4(24-51) 
Weight (kg) (mean and range) 82.7(69-101) 
Blood pressure (mm Hg) 184/118+12/6 
before therapy* 
(mean + SEM) 
Blood pressure (mm Hg) 150/97+6/2 
during therapy (sphyg-
momanometer) 
(mean + SEM) 
Dose of beta-blocker (mg/24 h) 
(mean and range) 
Propranolol 208(160-320) 
Metoprolol 260(200-400) 
Mean of measurements during last three visits to the outpatient 
.clinic before therapy started Measured by sphygmomanometer. 
Mean of measurements during last three visits before the infu-
sion experiments. 
inserted earlier into a left antecubital vein, epinephrine was 
infused in graded doses of 0.5, 1.0, 2.0 and 4.0 ug/min. Each 
infusion dose was sustained for 8 min. During the last 4 min of 
each infusion, three blood pressure and heart rate and two fore-
arm blood flow measurements were made, each consisting of five 
determinations. After discontinuation of the epinephrine infu-
sion the same measurements as before the infusion were repeated 
for 10 min. The measurements were done with the arm elevated 
obliquely in an arm support about 10 cm above heart level. 
Blood pressure was measured on the right arm by a semi-
automatic device (Artenosonde) . Heart rate was recorded by ECG. 
Forearm blood flow was measured, also in the right arm, by 
mercury strain-gauge venous occlusion plethysmography. The mean 
arterial pressure was calculated as the sum of the diastolic 
and a third of the pulse pressure. The vascular resistance in 
the forearm, expressed in arbitrary units, was computed by 
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dividing the mean arterial pressure by the blood flow in the 
forearm. 
In all patients blood samples were drawn before the start 
of the experiments for determination of the level of the beta-
blocking drug by a chromatographic method (5). In one patient 
blood was drawn through another catheter inserted in the left 
forearm for estimation of plasma norepinephrine and epinephrine. 
Estimation was done by a radioenzymatic assay (4). 
All results are presented as mean + SEM (unless otherwise 
indicated). Statistical analysis was performed by Student's 
t-test for paired observations. 
RESULTS 
Figure 1 is an example of the determinations from a 
representative subject. In this patient plasma levels of epine-
phrine during infusion at a rate of 0.5 ug/min amounted to four 
to six times the basal values, whereas a rate of 4 yg/min epine-
phrine induced a 20- to 25-fold rise in plasma epinephrine. 
Table 2 shows the hemodynamic effects of the epinephrine infu-
sion in both treatment periods. No difference was noted between 
the basal values m the periods. 
During metoprolol medication epinephrine induced an insig-
nificant rise in systolic pressure. There was no demonstrable 
effect on diastolic pressure, mean arterial pressure, or heart 
rate. There was no increase in forearm blood flow and thus fore-
arm vascular resistance did not change. 
Epinephrine m combination with propranolol induced a 
marked rise in systolic pressure only after the highest dose 
of epinephrine. However, the rises in diastolic and mean arter-
ial pressure was already substantial at the lowest infusion rate. 
The decrease in heart rate was substantial at the 0.5 pg/min 
rate and became more so at the higher doses. Propranolol treat-
ment induced a fall in forearm blood flow, whereas forearm vas-
cular resistance rose considerably. This rise was already 
evident at the lowest infusion rate. 
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Table λ. Hemodynamic effects of epinephrine infusion after metoprolol (M) and propranolol (P) in five hyper­
tensive patients 
Parameter Basal values 0.5 
During infusion (pg/min) 
1.0 2.0 4.0 after 
epinephrine 
Systolic pressure 
(mm Hg) 
Diastolic pressure 
(mm Hg) 
Mean arterial pres­
sure (mm Hg) 
Heart rate 
(bpm) 
Forearm blood flow 
(ml/100 ml.mm) 
Forearm vascular 
resistance (U) 
M 
Ρ 
M 
Ρ 
M 
Ρ 
M 
Ρ 
M 
Ρ 
M 
Ρ 
140+4 
141+7 
93+8 
93+8 
109+6 
109+7 
54+2 
57+4 
3.5+0.4 
3.0+0.5 
34+5 
42+10 
142+9 
146+10 
94+7 
98+8 
110+7 
114+8 
53 + 3 
54+4 
3.0+0.1 
2.3+0.3 
37+4 
54+10 
ΝΞ 142+9 
NS 152+13 
NS 92+8 
<0.05 102+8 
NS 109+7 
<0.01 119+9 
NS 53+3 
<0.05 53+4 
NS 3.1+0.2 
NS 2.2+0.3 
NS 36+3 
<0.05 59+3 
NS 
NS 
NS 
<0.01 
NS 
<0.05 
NS 
<0.05 
NS 
NS 
NS 
<0.05 
145+9 
156+13 
95+8 
107+10 
112+8 
123+10 
55+3 
51+4 
3.4+0.2 
2.0+0.4 
34+4 
68+14 
NS 
NS 
NS 
<0.01 
NS 
<0.05 
NS 
<0.05 
NS 
0.05 
NS 
<0.02 
151+12 NS 
174+15 <0.05 
92+6 NS 
114+10 <0.05 
112+7 NS 
134+11 <0.01 
55+4 NS 
47+5 <0.05 
3.9+0.3 NS 
2.0+0.5 0.05 
29^3 NS 
73+13 <0.05 
143+8 
139+6 
93+7 
89+6 
109+6 
106+6 
57+4 
61+4 
2.7+0.3 
2.5+0.7 
43 + 5 
63 + 12 
Mean values jf SEM are given before, during and after the various doses of epinephrine. Ρ values apply to the 
difference from basal value. NS = not significant. 
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Figure 1. Example of hemodynamic effect in one patient before 
and during epinephrine infusion after propranolol 
(left panel) and after metoprolol (right panel). 
Figure 2 presents the percent changes in the hemodynamic 
parameters induced by epinephrine in relation to the initial 
values. It is evident from these figures that the impressive 
pressor response, which was present during propranolol treat­
ment, was completely absent during treatment with metoprolol. 
This pressor response was noted after epinephrine infusion at a 
rate of 0.5 yg/min. 
The plasma level of metoprolol was a mean 464.8 nmol/1 
(range 84 to 720) and that of propranolol was 309.0 nmol/1 
(range 150 to 530), demonstrating that in all patients the 
plasma level of the drug was in the therapeutic range. 
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Figure 2. Percent changes in blood pressure, heart rate, forearm 
blood flow, and forearm vascular resistance induced by 
stepwise increase in epinephrine infusion after long-
term treatment with propranolol ( ) and metoprolol 
( ) in five hypertensive patients. *p<0.05 
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DISCUSSION 
It is well known that treatment with selective and non-
selective beta-blockers results in equal reduction of blood 
pressure and heart rate. Earlier studies, however, suggested 
that short-term rises in blood pressure could occur during non-
selective blockade, presumably by stress-induced epinephrine 
release (1, 10, 11) which would favor the use of beta-selective 
over non-selective blockers in the treatment of hypertension. 
We therefore studied the effect of epinephrine in levels closer 
to the normal range than in previous reports (8, 9) in order to 
simulate situations of daily life stress. 
Compliance of our five hypertensive patients to the beta-
blocking therapy was supported by the basal heart rates and 
plasma levels of the drugs. The fact that some of the patients 
used diuretics as well does not complicate the results because, 
as we have reported, these drugs do not change the hemodynamic 
reaction to epinephrine infusion (9). 
Our study demonstrates, that the marked difference in reac-
tion to epinephrine between the two kinds of beta-blockade is 
present at low infusion rates. Even the smallest dose of epine-
phrine (0.5 ug/min) induced a rise in diastolic blood pressure 
during propranolol treatment, but it did not do so during treat-
ment with metoprolol. At a dose of 1.0 yg/min epinephrine the 
blood pressure rise during interaction of epinephrine with 
propranolol caused an evident fall in heart rate, presumably 
due to baroreflex mediation. After infusion of 2.0 ug/min 
epinephrine vasodilation in the blood vessels of the forearm 
occurred in the metoprolol experiments; this process was re-
versed in the propranolol experiments and vasoconstriction 
occurred. This can be explained by the blocking of the vascular 
beta?-receptors while the available alpha-receptors are stimu-
lated. 
From our experiments it seems likely that infusion with 
smaller doses of epinephrine than 0.5 pg/min will cause only 
clinically unimportant dynamic differences in the effects of 
these two types of beta-blockers. 
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Little information is available in the literature on plasma 
epinephrine levels measured by modern methods during infusion. 
It is known that plasma epinephrine increases 200% to 400% at an 
infusion rate of 0.5 yg/min epinephrine (2, 6, 7). The plasma 
levels determined in one patient in our study are in this same 
range and levels in this range have also been reported during 
periods of stress that may occur in hypertensive patients (e.g., 
during cigarette smoking, surgery, angina pectoris, and myo-
cardial infarction) (3). Admittedly, these kinds of stress 
probably involve more complicated processes than does the infu-
sion of epinephrine, but we feel that our results have pointed 
to the probability that naturally occurring stress is able to 
induce sharp rises m blood pressure during non-selective beta-
blockade. It remains to be demonstrated, however, which daily 
life events induce these pressor responses before absolute 
priority can be given to beta -selective blockers for the long-
term treatment of hypertension. 
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CHAPTER IV 
EFFECTS OF COLD EXPOSURE ON BLOOD PRESSURE, HEART RATE 
AND FOREARM BLOOD FLOW IN NORMOTENSIVES DURING SELECTIVE 
AND NON-SELECTIVE BETA-ADRENOCEPTOR BLOCKADE 
H Houben, Th Thien, G Wijnands, A van 't Laar 
British Journal of Clinical Pharmacology 14 (in press) 1982 
SUMMARY 
Haemodynamxc effects of a cold pressor test (foot immersion 
during 6 minutes in water of 5 C) without medication and after 
the non-selective beta-adrenoceptor blocker propranolol and the 
selective beta-adrenoceptor blocker metoprolol were studied in 
17 volunteers. In the control study as well as in the study with 
the beta-adrenoceptor blockers cold exposure caused comparable 
changes, namely a blood pressure rise and a reduction of fore-
arm blood flow. The increase in heart rate during cold exposure 
was clearly and equally reduced by both beta-adrenoceptor 
blockers. Plasma noradrenaline rose significantly with 47%, 
plasma adrenaline did not change. It is concluded, that as to 
this kind of stress, beta -selective-adrenoceptor blockade con-
fers no important advantage over non-selective beta-adrenoceptor 
blockade. 
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INTRODUCTION 
Beta-adrenoceptor blocking drugs are frequently used in the 
treatment of hypertension and of angina pectoris. Their haemo-
dynamic effects in rest have been extensively studied. It seems 
important, however, to determine the haemodynamic effects of 
therapy not only at rest, but also during daily life stresses. 
Stress could induce different haemodynamic effects during beta-
selective and non-selective beta-adrenoceptor blockade. Adrena-
line infusion caused a strong pressor response during treatment 
with propranolol, but not with metoprolol (1, 2, 3). This could 
be explained by a blockade of beta -mediated vasodilation, 
whereas alpha-mediated vasoconstriction remains unopposed. How-
ever, adrenaline infusion may not be simply put on a level with 
stress. 
Cold exposure has frequently been used as an example of 
environmental stress. In the reaction to cold the sympathetic 
nervous system is activated and plasma adrenaline and noradrena-
line may increase (4). 
The aim of this study was to investigate, whether the 
haemodynamic effects of cold exposure were differenu during 
both types of beta-adrenoceptor blockade. The haemodynamic 
effects of cold exposure during blockade with propranolol have 
been extensively studied (5, 6, 7, 8). As far as we know only 
one study has been published on the influence of one of the now 
available selective beta-adrenoceptor blockers, i.e. atenolol, 
in a small group of patients (9). Comparative studies between 
selective and non-selective drugs have not yet been published. 
SUBJECTS AND METHODS 
Seventeen healthy volunteers (9 men and 8 women) with a 
mean age of 26.6 years (range 18-42 yr) participated in the 
study. All gave their informed consent. The relative body 
weight amounted to 103+10% (mean + SD). All volunteers were 
tested three times in a random order, i.e. a control study 
without medication, one after the administration of propranolol 
and one after metoprolol. They were asked to take three tablets 
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of 80 mg of propranolol or 100 mg of metoprolol during 16-18 
hours before the investigation. The last tablet was taken three 
hours before the test. 
After 30 minutes rest in the supine position the subjects 
were asked to immerse their right foot m a water bath at 5 С 
for 6 minutes. During the last 10 minutes before the test basal 
values of blood pressure (BP) and heart rate (HR) were measured 
five times. Three measurements of forearm blood flow (FBF) were 
made on the right forearm, which was elevated obliquely in an 
arm support about 10 cm above heart level. During the test BP 
and HR were measured each minute. FBF was also measured each 
minute, but not after the fifth minute. 
In eight of the control studies blood was drawn for nor­
adrenaline and adrenaline determination before and immediately 
after the test, via a catheter inserted in a left antecubital 
vein. 
During all experimental sessions temperature was held con­
stant: room temperature 22.0 C, water temperature 4.9 to 5.3 C. 
BP was measured by a semi-automatic device, Artenosonde 
1217. HR was registered by ECG. FBF was measured by mercury 
strain-gauge venous occlusion plethysmography, each measurement 
being the mean of three readings. 
Plasma noradrenaline and adrenaline were determined with a 
radio-enzymatic assay (10). 
Statistical analysis was carried out with the Student-t-
test for paired observations. Not significant (N.S.) means 
p>0.05. All values are given as mean + SEM. 
RESULTS 
Table 1 gives the effects of cold exposure from minute to 
minute. Both drugs reduce BP and HR significantly, basal FBF is 
not influenced. Cold induces a sharp rise in BP and HR and a 
fall m FBF. As to the latter two variables, changes are espe­
cially marked in the first minute. Only after propranolol FBF 
was significantly reduced during the whole test. 
In figure 1 a comparison is made of the cold induced changes 
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Table 1. Systolic blood pressure (SBP), diastolic blood pressure (DBP), heart rate (HR) and 
forearm blood flow (FBF) before (basal) and during cold exposure in 17 normotensive 
volunteers-
basal 1' 2' 3' 4' 5' 6' 
SBP С 114+2 132+3 131+3 130+3 126+2 124+2 122+3 
mm Hg Ρ 102+2 121+3 121+3 116+2 115+2 114+2 113+2 
117+3 117+3 115+3 115+3 114+2 
DBP С 73+2 89+2 91+2 87+2 85+2 85+2 84+2 
mm Hg Ρ 67+2 86+2 85+2 82+2 80+2 79+2 76+1 
81+3 79+3 79+2 78+2 77+2 
HR С 63+2 76+3 69+3 67+3 69+3 66+3 66+2 
beats/mm Ρ 51+2 56+2 55+2 54+2 53+2 52+2 NS 54+2 
58+3 56+2 55+2 55+2 54+2 
FBF С 4.5+0.5 3.4+0.4* 3.9+0.4 NS 3.8+0.4 NS 3.9+0.5 NS 4.0+0.5 NS 
ml/100 ml.min Ρ 4.2+0.5 2.6+0.3*** 3.0+0.3** 3.4+0.4* 3.2+0.2** 3.4+0.4* 
M 3.6+0.4 2.6+0.2*** 2.9+0.3* 3.0+0.4 NS 3.2+0.4 NS 3.0+0.4 NS 
In every individual three tests have been performed: without medication (C), during proprano­
lol (P) and during metoprolol (M). Results are given as mean + SEM. Statistical comparisons 
have been made against basal values in the respective tests. As to SBP, DBP and HR only non­
significant changes are indicated (NS) . P-values relating to basal FBF values p<0.05, 
**p<0.01, ***p<0.001. 
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Figure 1. Changes from basal values in blood pressure, heart rate 
and forearm blood flow during cold exposure in 17 
volunteers in control experiments and after propranolol 
and metoprolol. Mean values + SEM are given. 
'•p<0.05; rp<0.001 
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obtained m the three experiments. For this purpose the mean 
changes after 2 to 6 minutes are given separately. The increase 
m BP and the fall in FBF during cold exposure are not influ-
enced by both drugs. The rise in HR during the first minute was 
evidently attenuated by beta-adrenoceptor blockade. 
The determinations of plasma noradrenaline and adrenaline 
before and after cold exposure in 8 subjects gave the following 
results. Noradrenaline rose from 1.20+0.20 to 1.71+0.31 nmol/1 
(p<0.01). Mean plasma adrenaline did not change: before 0.13+0.02 
and after 0.13+0.01 nmol/1. 
DISCUSSION 
The modification of the classic cold pressor test (immer-
sion of a hand for 1 m m in water of 0 C) used in this study 
was chosen in order to get the opportunity for multiple measure-
ments on both arms during the immersion of an extremity in cold 
water. Because, according to some authors (11) adaptation may 
occur on repetition of the test, the sequence of the three tests 
had to be randomized. 
In earlier studies (1, 2, 3), we showed that the infusion 
of adrenaline induces vasoconstriction and a considerable rise 
in BP in hypertensive patients, when they are treated with the 
non-selective beta-adrenoceptor blocker propranolol. During 
treatment with the beta -selective adrenoceptor blocker meto-
prolol, however, the normal reaction to adrenaline (vasodilation 
in muscle) was maintained as appeared from an increase in FBF. 
However, we did not find a difference in the effects of exposi-
tion to cold between treatments with propranolol and metoprolol. 
The fact that plasma noradrenaline increased, whereas plasma 
adrenaline did not change significantly may explain this finding 
and fits in with the decrease of FBF and the rise of both SBP 
and DBP. 
In our study FBF was measured with plethysmography. From 
the table it may be suggested that differences in basal values 
of the three experiments, although not significant, are substan-
tial. However, measurement of FBF by plethysmography is only 
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suitable for detecting changes during short-term experiments 
(12). Therefore, absolute values have been compared only with 
the basal values of the same experiment. In all three experi-
ments cold induced a significant fall of FBF. This fall is 
modest, probably because skin flow is minimal due to an environ-
mental temperature of 22 C. At a temperature of 28 C, when 
skin flow is greater, stronger reduction of FBF is found (13). 
After propranolol alpha-adrenergic stimulation durino cold 
exposure is possibly more pronounced, as FBF seems to be reduced 
longer than in the other tests. 
In conclusion, the beta -selective adrenoceptor blocker 
metoprolol and the non-selective beta-adrenoceptor blocker pro-
pranolol have the same effects on BP and HR during cold exposure. 
Both drugs do not prevent a rise in BP, but attenuate equally 
the increase in HR. The fall in FBF induced by cold was essen-
tially similar after both medications and m the control 
experiment. 
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SUMMARY 
Several studies report a substantial rise in plasma cate-
cholamines after the ingestion of caffeine. Epinephrine infusion 
causes a pressor response after treatment with non-selective 
beta-blockade. We studied the hemodynamic and humoral effects of 
the drinking of coffee after placebo and both after non-selective 
(propranolol) and beta -selective blockade (metoprolol) in twelve 
normotensive volunteers. After placebo coffee induced a rise in 
systolic as well as diastolic blood pressure and a fall in heart 
ratejWhereas forearm blood flow did not change. Plasma catecho-
lamines, especially epinephrine (+150%), rose and PRA fell sig-
nificantly after the drinking of coffee. The effects of coffee 
on blood pressure, forearm blood flow and all humoral parameters 
were not altered by pretreatment with propranolol or metoprolol. 
The fall in heart rate after coffee, however, seemed to be stronger 
during propranolol. We conclude that the rise in plasma epinephrine 
after the drinking of coffee was just too small to reveal differen-
ces in reaction m propranolol- and metoprolol-pretreated sub-
jects. 
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INTRODUCTION 
In previous studies from our department hemodynamic 
effects of epinephrine infusions after pretreatment with 
beta.- and non-selective beta-adrenergic blockade have been 
reported (16, 18, 19). After metoprolol the normal vasodila-
tory reaction to epinephrine was largely maintained,whereas 
after propranolol a vasoconstrictive or pressor response was 
observed. This pressor response could be explained by the 
blockade of beta„-adrenergic receptors by propranolol, 
leaving the alpha-adrenergic vasoconstriction due to epine-
phrine unopposed. This so called "unopposed alpha-effect" 
results in an increase in total peripheral resistance,which 
is responsible for the pressor response. In the literature 
possible spontaneously occurring examples of this phenomenon 
have been described (2, 21, 24). The clinical relevance, 
however, has not been fully elucidated. Until now it has 
not been proved that stresses of daily life can also result 
in a pressor response during treatment with propranolol. 
Since the ingestion of caffeine results in an increase 
in plasma catecholamines (25, 26, 27), drinking of coffee can 
be considered as such a stress. The aim of this study was to 
find out whether drinking of coffee results in different 
hemodynamic effects after pretreatment with propranolol and 
metoprolol. 
SUBJECTS AND METHODS 
Twelve normotensive healthy volunteers (nine men, three 
women) ranging in age from 17 to 38 years gave their informed 
consent to the study. All volunteers were habitual coffee 
drinkers (mean: 4,5; range: 2-8 cups of coffee per day). 
Lengths and body weights (mean + SD) of the subjects amounted 
to 182.5+10,0 cm and 72.7+12,1 kg. 
Each subject took part in three tests in random order in 
which they received two cups of coffee after placebo, propra-
nolol (240 mg) and metoprolol (300 mg) respectively. These 
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doses were given in a double blind fashion and were split up 
in three tablets,which were taken 15, 9 and 1 hour before the 
start of each test. The three tests were separated from each 
other by at least three days. Before each test the subjects 
had to abstain from caffeine-containing products for at least 
17 hours and from smoking for 10 hours. 
After arrival at the laboratory the subjects rested for 
twenty minutes in the supine position. This period of rest was 
started with the insertion of a catheter in an antecubital vein 
of the left arm, followed by the connection of the Artenosonde 
and the Plethysmograph to the subjects right arm, which was 
placed in an arm support 5 to 10 cm above heart level. After 
this initial period five registrations of blood pressure (BP) 
and heart rate (HR) were made each five minutes. After the first 
measurement blood was drawn for determining blood levels of 
caffeine, plasma renin activity (PRA) and catecholamines. 
Between the following four measurements three series of five 
forearm blood flow (FBF) registrations were made. After that, 
the subjects were asked to drink two cups of coffee within 
10 minutes. Forty minutes afterwards exactly the same periods 
of rest and measurements were repeated. In figure 1 the pro­
tocol is illustrated by an example of a coffee test after 
propranolol. 
Coffee was prepared according to a standardized method 
using 350 ml of water and 24 grams of coffee. This resulted 
in two cups of coffee each containing 150 ml. 
BP was measured with the Artenosonde 1225 and HR was 
calculated from an electrocardiographic registration. FBF was 
measured using u mercury strain-gange venous occlusion Plethys­
mograph. Since we wanted to measure only changes in muscle 
flow, room temperature was kept between 19.0° and 20.5OC (1). 
Samples for determination of plasma caffeine were analy­
zed with a reversed phase HPLC-method. For this determination 
a Spectra Physics 3500 В machine was used. The column (stain­
less steel, length 15 cm, internal diameter 4,6 mm) was packed 
with Lichrosorb RP8, 5y particle size. Detection was affected 
at 270 nm with a UV detector model SP770. An injection loop 
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Figure 1. Blood pressure, heart rate and forearm blood flow 
before and after the ingestion of coffee m one 
subject after pretreatment with propranolol. Presen­
ted values of FBF are all mean values of five 
registrations. At the time indicated by the arrows 
blood was sampled for humoral parameters. 
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of 100 μΐ was used. The solvent was a mxxture of sodium 
acetate (0.02 M) and 20% methanol. Solvent flow measured 
1.2 ml/mm. The sample was prepared by mixing 100 μΐ of plasma 
with 400 μΐ perchloric acid 0.23 N. The mixture was centri­
fugea and 100 μΐ of the clear supernatant was injected onto 
the column. Catecholamines were measured by a radio-enzymatic 
assay (17) and PRA by a radio-immuno assay (7). In seven 
subjects plasma concentration of propranolol and metoprolol 
were determined using a gas chromatographic method (9). 
The hemodynamic and humoral effects of coffee after pro­
pranolol and metoprolol were compared with each other and with 
the results of the placebo test. For each subject all measure­
ments of BP, HR and FBF were avaraged both before and after the 
ingestion of coffee. For statistical analysis the Student-t-
test for paired observations was used. At P-values of less than 
0.05 differences were considered to be statistically signifi­
cant. Mean arterial pressure (MAP) was calculated as the sum 
of diastolic blood pressure (DBP) and one third of pulse pres­
sure. Forearm vascular resistance (FVR) was calculated by di­
viding MAP through FBF and expressed in arbitrary units. 
All results are presented as mean ± SEM. 
RESULTS 
Figure 2 shows the values of BP, HR and FBF before and 
after use of coffee in the placebo, propranolol and metoprolol 
test. Mean basal values of BP and HR after placebo measured 
116/69 + 2/2 mm Hg and 63 ± 3 beats/min. Both beta-blockers sig­
nificantly reduced BP and HR. After propranolol and metoprolol 
basal BP amounted to 108/65 ± 2/1 mm Hg and 108/64 ± 1/1 mm Hg 
and HR 56 ± 1 and 54 ± 1 beats/min respectively. 
The drinking of coffee induced a rise in blood pressure and 
a fall in heart rate. The mean percentual rise in systolic blood 
pressure (SBP) after coffee during the placebo, propranolol 
and metoprolol test measured respectively 4% ,7% and 7%, those 
in DBP 16%, 22% and 19%. These elevations all reached statis­
tical significance, but did not differ significantly from 
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Figure 2. Blood pressure, heart rate and forearm blood flow 
before (b) and after (a) the ingestion of coffee in 
the placebo, propranolol and metoprolol test in 12 
normotensives (mean ± SEM) 
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each other. After coffee ingestion HR fell significantly in 
all three tests. After propranolol the fall in HR of 7 beats/mm 
was significantly greater than the fall of 4 beats/min in both 
other tests. Table 1 shows mean values of the changes m BP 
and HR after drinking coffee in the three tests. Basal FBF 
after placebo, propranolol and metoprolol amounted to 3.1+0.4, 
2.8+0.3 and 3.0+0.5 ml/100 ml.mm and after coffee these values 
showed an insignificant fall to 2.9+0.3, 2.4+0.2 and 2.3+0.2 
respectively. Calculated FVR rose from 31+2.9 to 38+4.6 units 
in the placebo test, after propranolol from 31+3.5 to 42+4.0 
units and after metoprolol from 32+4.0 to 41+3.5 units. Only 
m the propranolol test the elevation in FVR reached statistical 
significance. 
Mean basal plasma concentrations of caffeine were identi-
cal in all three tests and amounted to 0,3 pg/ml (range: 
<0.2-1.0 ug/ml). Sixty minutes after the ingestion of coffee 
mean concentrations were raised to 8.2+0.8, 7.8+0.5 and 7.9+0.6 
yg/ml m the placebo, propranolol and metoprolol tests (range: 
4,9-14.1 yg/ml). 
The basal PRA after propranolol (1.49+0.36 ng/ml.hr~ ) 
was significantly lower than after placebo (2.43+0.50 ng/ml.hr ) 
whereas basal PRA after metoprolol (1.87+0.51 ng/ml.hr ) was 
not significantly lower. In all tests coffee induced a signi-
ficant fall in PRA to 1.75+0.24 (placebo), 0.99+0.25 (propra-
nolol) and 1.00+0.18 ng/ml.hr" (metoprolol). 
Basal plasma epinephrine and norepinephrine were highest 
after metoprolol and lowest after placebo, but were not signifi-
cantly different from each other. During placebo, propranolol 
and metoprolol epinephrine rose significantly after coffee 
drinking with 147%, 153% and 157% respectively. The rise in 
plasma norepinephrine after coffee ingestion was significant 
in the placebo test and measured only 19%. Table 2 shows all 
results concerning the plasma catecholamines. 
Mean plasma concentrations of propranolol and metoprolol 
determined in seven subjects amounted to 289 nmol/1 (range: 
82-690 nmol/1) and 703 nmol/1 (range: 330-1150 nmol/1) respec-
tively. 
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TABLE 1. C h a n g e s (Д) i n s y s t o l i c b l o o d p r e s s u r e ( S B P ) , d i a s t o l i c 
b l o o d p r e s s u r e (DBP), mean a r t e r i a l p r e s s u r e (MAP) a n d 
h e a r t r a t e (HR) d u e t o c o f f e e i n g e s t i o n a f t e r p l a c e b o , 
p r o p r a n o l o l a n d m e t o p r o l o l (mean ± SEM) 
Placebo PI Propranolol P2 Metoprolol P3 
Δ SBP (im Hg) 5 ± 1.4 NS 7 ± 1.2 NS 8 ± 1.2 NS 
Δ DBP (mmHg) 11 ± 2.0 NS 14 ± 2.1 NS 12 ± 1.4 NS 
Δ MAP (mmHg) 9 + 1 . 4 NS 11 + 1.2 NS 11 + 1.2 NS 
Δ HR (beats/min) -4 ± 1.4 P<0.05 -7 ± 0.9 P=0.08 -4 + 1.4 NS 
NS = not s i g n i f i c a n t 
PI = p l a c e b o vs p r o p r a n o l o l 
P2 = p r o p r a n o l o l vs m e t o p r o l o l 
P3 = m e t o p r o l o l vs p l a c e b o 
TABLE 2. Plasma l e v e l s of e p i n e p h r i n e (Ε), and n o r e p i n e p h r i n e 
(NE) b e f o r e and a f t e r t h e use of cof fee in t h e 
p l a c e b o , p r o p r a n o l o l and m e t o p r o l o l t e s t (mean + SEM) 
Placebo Propranolol Metoprolol 
before after before after before after 
E (niTOl/1) 0.15+0.01** 0.37+0.08 0.17±0.02** 0.43+0.09 0.21±0.04* 0.54+0.15 
NE(nnr>l/l) 1.55+0.18* 1.B5±0.18 1.75±0.16 NS 2.12+0.27 1.89±0.37NS 2.13±0.27 
*P<0,02; * * P < 0 , 0 1 ; NS = n o t s i g n i f i c a n t 
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DISCUSSION 
Caffeine-containing products such as coffee, tea, cola-
flavoured drinks, cacao and chocolate are widely used in the 
whole world. So, the pharmacoloqical effects of caffeine and 
eventual interactions with beta-blockade could be of great 
clinical importance. Many organ systems, e.g. the gastro-
intestinal tract, the central nervous system the kidneys and 
the cardiovascular system, are influenced by caffeine (8). 
Possible pharmacological mechanisms for the cardiovas-
cular effects of this drug are the inhibition of the enzyme 
phosphodiesterase (4), the antagonism of endogenous adenosine 
(12) and the influence on intracellular Ca concentration (8), 
which all can be described as peripheral direct mechanisms. 
The hemodynamic effects of caffeine could be partly based on 
the increased release of catecholamines and on a rise in PRA 
(25). Besides the former direct and the latter indirect peri-
pheral mechanisms, central stimulation of vagal centers and of 
the vasomotor center in the brainstem could be important me-
chanisms for the cardiovascular effects of caffeine (31). 
Surveying the literature on the hemodynamic effects of 
caffeine an increase in BP has been observed (11, 13, 25, 31). 
In some studies, however, this effect could not be affirmed 
(15, 28). The effects of caffeine on heart rate also are contro-
versial (6, 15, 25, 29). As far as we know there is no litera-
ture available on the effects of coffee on FBF. After infusion 
of the methylxanthme theophylline an increase in FBF has been 
observed (23). As a result of the direct relaxating effect of 
caffeine on smooth muscle cells (8), but also via epinephrine 
mediated beta2-receptor stimulation a rise in FBF could also 
be expected after the drinking of coffee. In our study FBF was 
not changed by the ingestion of coffee. Differences m ex-
perimental design and tolerance to the effects of caffeine could 
be responsible for all these contradictions in the literature 
on the hemodynamic effects of caffeine (6, 27). With regard to 
this tolerance Robertson (27) suggested that an abstinence of 
caffeine for more than 24 hr was required for maximal BP response. 
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In our study we measured considerable changes in hemodynamics 
after an abstinence period of at least 17 hr. Sixty minutes af-
ter the drinking of coffee we observed in the placebo test an 
increase in BP and a fall in HR. After caffeine a fall in total 
peripheral resistance has been reported (15, 28). Since we did 
not observe a fall in FVR in all three tests, whereas DBP sho-
wed a rise, the latter being mere pronounced than that in SBP, 
our results indicate that an increase in total peripheral re-
sistance takes place. 
In our study the rises in plasma epinephrine after coffee 
always exceeded those in plasma norepinephrine. Since we are 
looking for hemodynamic interactions between propranolol and 
daily life stresses with a rise in plasma epinephrine, drinking 
of coffee seems a suitable stress stimulus for this st^dy. 
Neither basal plasma catecholamines nor the response of cate-
cholamines to coffee were changed by pretreatment with beta-
blockers. As could be expected both propranolol and metoprolol 
lowered basal PRA (3). After the ingestion of coffee PRA de-
creased in all three tests. These observations are in contrast 
with the results of other studies (25, 32, 33), which all re-
ported an increase in PRA after methylxanthines. True enough, 
we do not have an explanation for the observed decrease in PRA, 
but anyway, we can conclude that it is unlikely that in our 
study the effect of coffee on BP is mediated by the renin-
angiotensin system. 
Single dose studies with the cardioselective beta-antago-
nists atenolol and metoprolol have revealed an acute hypotensive 
response in normotensives after both drugs (10, 20). After oral 
administration of 80 mg propranolol Thadini (30) measured an 
acute fall in SBP, but according to Bühler (5) the fall in BP 
only gets through after several days. In our study BP decreased 
within 15 hours to identical values after both metoprolol and 
propranolol. The wide range of plasma concentrations of both 
beta-blockers in in close agreement with other studies (22, 30) 
and is the result of the тазог first pass removal of these 
drugs by the liver. With respect to this there is no evidence 
for lack of compliance with the beta-blocker pretreatment m this 
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study. 
Concerning the primary aim of our study we could not re-
veal differences in BP response to the ingestion of coffee du-
ring the three tests. Reactions of FBF to coffee also were 
identical throughout the three tests. So, this study did not 
show an "unopposed alpha-effect" after drinking coffee in the 
propranolol test. Previously, we have studied (19) the effect 
of low-dose epinephrine infusion on hemodynamics after selec-
tive and non-selective beta-blockade in hypertension. At the 
lowest rate of infusion, which corresponded with a rise in 
plasma epinephrine of 200-400%, we observed significant dif-
ferences in reaction in propranolol- and metoprolol-treated 
patients. Since in our study plasma epinephrine rises with 
150-160% after coffee, the stress stimulus used in this study 
probably was just too small to reveal differences in hemodyna-
mics between the propranolol and metoprolol test. 
During the propranolol test the fall in HR was stronger 
than in both other tests. This could be the result of the 
chmidine-like properties of propranolol. After in vivo- and 
m-vitro experiments with rats Strubelt (29) concluded that 
propranolol inhibited the positive chronotropic effect of 
methylxanthines in rats not only as a result of the beta-recep-
tor blocking properties of propranolol, but also by its mem-
brane stabilizing activities. Since metoprolol has no membrane 
stabilizing activity this mechanism may have contributed to 
the greater fall in HR after propranolol. 
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CHAPTER VI 
HAEMODYNAMIC EFFECTS OF CIGARETTE SMOKING DURING CHRONIC 
SELECTIVE AND NON-SELECTIVE BETA-ADRENOCEPTOR BLOCKADE IN 
PATIENTS WITH HYPERTENSION 
H Houben, Th Thien, A van 't Laar 
British Journal of Clinical Pharmacology 12: 67-72 (1981) 

SUMMARY 
Haemodynamic effects of cigarette smoking before and during 
chronic treatment with propranolol and metoprolol were studied 
in 16 patients with essential hypertension. 
Smoking of cigarettes induced an increase in blood pressure 
of the same degree in all experimental sessions. Heart rate 
increased by 16 beats/nun during smoking alone, but increased 
significantly less, when a beta-adrenoceptor blocker was used. 
Forearm blood flow decreased during smoking in both medication 
periods. 
Plasma adrenaline rose significantly during smoking from 
0.37 nmol/1 to 0.77 nmol/l; plasma noradrenaline did not change. 
It is concluded that the blood pressure changes induced by 
smoking are not essentially altered during chronic treatment 
with selective or non-selective beta-adrenoceptor blockade. Only 
the increase in heart rate is significantly less pronounced 
during treatment with both drugs. 
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INTRODUCTION 
Previous studies from our department have revealed diffe-
rent haemodynamic reactions to adrenaline during chronic anti-
hypertensive treatment with non-selective and beta -selective 
adrenoceptor blocking drugs (1, 2). During treatment with 
propranolol an unfavourable pressor response was observed. 
Mean arterial pressure (MAP) increased, heart rate (HR) de-
creased, forearm blood flow (FBF) fell and, consequently, the 
calculated forearm vascular resistance increased. During meto-
prolol treatment the normal reaction to adrenaline remained 
undisturbed (viz. a slight increase m systolic blood pressure 
(SBP) and heart rate, no change in diastolic blood pressure 
(DBF), an increase in forearm blood flow and a decrease m cal-
culated forearm vascular resistance). It remains questionable, 
however, whether this difference in reaction is of clinical 
importance. In other words, do stresses of daily life lead to 
pressor responses during non-selective beta-adrenoceptor 
blockade? 
An example of daily life stress is cigarette smoking, a 
so-called inactive stress (3). The stress of cigarette smoking 
is a consequence of the complex action of nicotine, which is 
supposed to induce haemodynamic changes via one or more of the 
following mechanisms. Firstly, nicotine stimulates directly the 
chemoreceptors of the aortic and carotid bodies and this by 
reflex results in vasoconstriction, tachycardia and elevated 
blood pressure (4). Secondly, nicotine activates the parasym-
pathetic nervous system, but this holds especially for non-
smokers (3). Thirdly, nicotine influences the sympathetic ner-
vous system, inducing a rise in plasma noradrenaline and ad-
renaline concentrations (5). 
Recently Trap-Jensen et al. (6) studied the influence of 
cigarette smoking on haemodynamics in healthy volunteers after 
a single intravenous administration of a selective and a non-
selective beta-adrenoceptor blocker. They found a marked rise 
in MAP during smoking after propranolol, whereas this response 
was not observed during smoking after atenolol. The aim of our 
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study was to investigate the haemodynamic changes induced by the 
smoking of cigarettes in patients with essential hypertension 
before and during chronic oral treatment with selective and 
non-selective beta-adrenoceptor blocking drugs. 
METHODS 
The clinical data of the patients are given in table 1. 
All patients gave their informed consent before entering the 
study. All had mild or moderate essential hypertension, without 
signs of organ damage, and were habitual (> 20 cigarettes daily) 
smokers. 
Table 1. Clinical data of the hypertensive patients 
Number 16 
Male/female 12/4 
Age (years) 37.6(18-56) 
(mean and range) 
Body weight (kg) 75.5(62-92) 
(mean and range) 
Blood pressure (mm Hg) 168/109+18/10 
before therapy (sphygmomanometer) 
(mean + s.d.) 
Dose (mg/24 h) 
(mean and range) 
propranolol 225(80-480) 
metoprolol 281(100-600) 
Seven patients were untreated at the start of the study. 
In this group the first smoking test was performed without 
medication and subsequently treatment with propranolol was 
started. After at least 4 weeks the second smoking test was 
performed. Thereafter, propranolol was substituted by metopro-
lol, 80 mg of propranolol being considered equipotent to 100 mg 
of metoprolol. After at least 4 weeks on metoprolol the third 
smoking test was performed. 
The other nine patients were chronically treated with 
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propranolol; the dosage varied from 160 mg to 480 mg daily (mean 
240 mg daily). The duration of this medication varied from 1 
month to 4 years (mean 21 months). After the smoking test during 
propranolol treatment they were given metoprolol. After at least 
4 weeks' treatment with metoprolol the next smoking test was 
carried out. 
The smoking tests were performed in the morning, 2 to 5 h 
after ingestion of the morning dose, in a room with a constant 
temperature of 19.4+0.8 С (mean + s.d.). The patients were 
allowed a light breakfast without coffee, but had to abstain 
from smoking from midnight. During the test the patients re­
mained recumbent. 
After 20 m m of rest, basal measurements started. From 20-
30 m m blood pressure and heart rate were measured at 2 m m 
intervals and eight forearm blood flow registrations were made 
during the last 3 m m before the start of smoking. Within 10-12 
m m the patients smoked two-thirds of two standard non-filtered 
cigarettes, inhaling in their habitual manner, but at least two 
times/min. Each cigarette contained 1.54 mg nicotine. During 
smoking, blood pressure and heart rate were measured every 2 
mm. Blood pressure was measured on the right arm, while the 
arm was elevated obliquely in an arm support about 10 cm above 
heart level. At the same side forearm blood flow was measured 
eight times during the last 3 m m of smoking. 
In seven studies plasma noradrenaline and adrenaline levels 
were measured before and immediately after smoking. Blood was 
drawn via an inserted catheter in a left antecubital vein. Fur­
thermore, in 11 studies the concentration of the beta-adreno-
ceptor blocker in plasma was determined. 
Blood pressure was measured with the Artenosonde 1217. 
Mean arterial pressure was calculated as the sum of the diastolic 
and 1/3 of the pulse pressure. Heart rate was registered by ECG. 
Forearm blood flow was measured using a mercury stain-gauge 
venous occlusion Plethysmograph. Adrenaline and noradrenaline 
were determined with a radio-enzymatic assay (7). The beta-
adrenoceptor blocker levels were determined using a gas chroma­
tography method (8). 
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Statistical analysis 
The values of all registrations before smoking and all 
registrations of the last three minutes during smoking were 
used for statistical analysis, using a two-way analysis of vari-
ance (fixed effects). Estimates of main effects and their stan-
dard errors (s.e.) were computed accordingly. Multiple compari-
sons were carried out using Scheffé's (1959) S-method (9). 
Plasma noradrenaline and adrenaline levels before and after 
smoking were compared with Wilcoxon's signed rank test. P-values 
of less than 0.05 were considered to be significant. All values 
are given as mean + s.e., unless indicated otherwise. 
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Figure 1. The influence of smoking cigarettes on blood pressure, 
heart rate and forearm blood flow in one patient 
during treatment with propranolol or metoprolol. 
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RESULTS 
Figure 1 shows a representative example of the haemodynamic 
changes caused by cigarette smoking during propranolol and meto-
prolol treatment m the same patient. 
Firstly, we present the results in the seven patients, who 
were untreated at the start of the study. Smoking without medi­
cation caused an increase in SBP and DBP of respectively 8+1.6 
mm Hg and 9+1.0 mm Hg (figure 2). The increases of systolic as 
well as diastolic blood pressure were not significantly changed 
during treatment with either beta-adrenoceptor blocker. Heart rate 
however, rose 16+0.9 beats/min during smoking alone and 11+0.9 
and 7+0-9 beats/mm during smoking while on propranolol and 
metoprolol respectively, both being significantly different 
from the control value and from each other. 
Smoking alone caused a significant increase of forearm 
blood flow (1.5+0.1 ml 100 ml" m m " 1 ) . In contrast, FBF was 
reduced during smoking on beta-adrenoceptor blockade and this 
decrease was significantly greater with metoprolol than with 
propranolol. 
The results in all 16 patients are summarized in table 2. 
It should be noted, that blood pressure values, listed here, 
are lower, than those obtained by conventional sphygmomanometry, 
because of both the elevated position of the arm and the use of 
an automatic device. The haemodynamic changes during smoking in 
the 16 patients were essentially the same as in the seven 
patients. During both treatment periods all haemodynamic para­
meters changed significantly from baseline values. Smoking 
caused a similar rise in SBP (6+1.0 ν 6+1.0 mm Hg), in DBP 
(6+0.7 ν 5+0.7 mm Hg) and in MAP (6+0.6 ν 6+0.6 mm Hg) during 
treatment with propranolol and metoprolol respectively. Heart 
rate increased significantly less on metoprolol: 8+0.4 beats/min, 
in comparison with propranolol: 12+0.4 beats/min. The decrease 
of forearm blood flow during smoking was significantly more 
pronounced on metoprolol than on propranolol. 
Determination of plasma adrenaline and noradrenaline before 
and after smoking without medication gave the following results 
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Figure 2. Changes in systolic and diastolic blood pressure, 
heart rate and forearm blood flow induced by smoking 
cigarettes during a period without treatment and 
during treatment with propranolol and metoprolol, 
each used for at least 4 weeks, in seven hypertensive 
patients. Mean + 1 
*p<0.05, **p<0.01 
results are given. 
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Table 2. Blood pressure, heart rate and forearm blood flow, before and during cigarette 
smoking in 16 patients during chronic treatment with propranolol and metoprolol 
Arterial blood pressure 
(mm Hg) 
systolic 
diastolic 
mean 
Before 
131+0.5 
81+0.4 
98+0.3 
Propranolol 
During 
137+0.8 
87+0.6 
104+0.5 
pi 
<0.001 
<0.001 
<0.001 
Before 
127+0.5 
80+0.4 
95+0.3 
Metoprolol 
During 
133+0.8 
85+0.6 
101+0.5 
Pl 
<0.001 
<0.001 
<0.001 
P2 
NS 
NS 
NS 
Heart rate (beats/min) 58+0.2 69+0.4 <0.001 55+0.2 63+0.4 <0.001 <0.001 
Forearm blood flow 3.2+0.1 2.9+0.1 <0.01 3.6+0.1 2.8+0.1 <0.001 <0.001 
(ml 100 ml _ 1min _ 1) 
Mean values +_ s.e. are given Ρ indicates differences between "before" and "during". 
Ρ indicates differences in haemodynamic changes as a consequence of smoking between the 
propranolol and metoprolol periods. 
NS = Not significant. 
(mean + SEM): adrenaline rose from 0.37+0.03 co 0.77+0.22 nmol/1 
(p<0.05). Mean plasma noradrenaline amounted to 1.80+0.36 before 
smoking and 1.95+0.31 nmol/1 after smoking (NS). 
All determinations of the beta-adrenoceptor blockers in 
plasma gave values in the therapeutic range: 788+181 nmol/1 
(mean + SEM). 
DISCUSSION 
The model of the smoking test, used in this study, seems 
a normal daily life stress for moderate to heavy smokers. 
The observed haemodynamic changes during smoking without 
medication are compatible with those reported in the literature 
(5). Reports from the literature (10) and our own unpublished 
observations have shown that the haemodynamic reaction caused 
by smoking of cigarettes in hypertensives does not differ from 
that in normotensives. 
In our study the sequence of medication periods was not 
randomized and not blind, and there was no placebo period. How-
ever, such a protocol was not necessary, since the haemodynamic 
changes caused by smoking are easily reproducible (11), and all 
measurements were objectively recorded. Furthermore, the 
patients had to be on chronic treatment and then the heart rate 
distinguishes the drug periods from placebo. Therapy compliance 
was good, as can be seen from both baseline heart rate and the 
plasma levels of the agents, determined in 11 unselected 
patients. 
In contrast to the effect of adrenaline infusion, we did 
not find an important difference as to smoking-mduced changes 
between selective and non-selective beta-adrenoceptor blockade 
in this study. The relatively small increase (100%) in the plas-
ma adrenaline levels may explain the fact that no difference m 
blood pressure rise could be found. If the increase in forearm 
blood flow is a consequence of adrenaline release, then during 
propranolol treatment a marked decrease in FBF and a blood 
pressure rise would have been expected. However, such a pressor 
response was not observed. Probably other effects of nicotine 
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have influenced the results. This also becomes evident from the 
increase in diastolic blood pressure in the untreated patients, 
since during adrenaline infusion DBP does not rise. 
Our results are in contrast with the data, reported by 
Trap-Jensen et al. (6). It remains difficult, however, to com-
pare their results with ours, because their study comprised 
healthy volunteers and the beta-adrenoceptor blocking agents 
were administered intravenously. It is generally accepted that 
the haemodynamics during a single intravenous dose are not 
similar to the effects of long-term oral beta-adrenoceptor 
blockade (12, 13). Moreover the nicotine content of the ciga-
rettes in the study of Trap-Jensen et al. (6) was twice as high 
as in ours, resulting in a much higher adrenaline release (14). 
However, cigarette smoking tests performed by others also did 
not result in such dramatic increases in adrenaline. For 
example in the study of Cryer et al. (5) adrenaline rose from 
0.24 to 0.62 nmol/1 and in the study of Brandsborg et al. (15) 
adrenaline rose from 0.27 to 0.71 nmol/1, both corresponding 
with the increase in our study from 0.37 to 0.77 nmol/1. All 
these findings are in strong contrast with the increase in 
adrenaline reported by Trap-Jensen et al. (6) from 0.12 to 1.83 
nmol/1. This difference may partly be explained by the extreme-
ly high nicotine content (2.8 mg/cigarette). 
Smoking of cigarettes causes reduction of skin blood flow, 
but the reports about the effect on muscle blood flow are con-
flicting (16). In our study basal skin blood flow is minimal, 
because room temperature was held constantly low. However, it 
cannot be excluded that further cutaneous vasoconstriction may 
have influenced total forearm blood flow during beta-adreno-
ceptor blockade. 
In conclusion, our results show that in hypertensive 
patients the rise of blood pressure during smoking remains 
unchanged during chronic treatment with both non-selective and 
selective beta-adrenoceptor blockers. Both drugs inhibit the 
increase in heart rate, caused by the smoking of cigarettes. We 
cannot conclude, therefore, that beta -selective adrenoceptor 
blocking drugs should be preferred in the treatment of hyper-
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tension in habitual smokers. 
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CHAPTER VII A 
ISOMETRIC EXERCISE AND MENTAL ARITHMETIC 
some hemodynamic characteristics, variability and 
reproducibility of the tests and the effect on 
plasma catecholamines 
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INTRODUCTION 
In the preceding chapters the effects of a number of stress 
tests (the application of cold, the drinking of coffee and the sno-
king of cigarettes) were studied. Based on this work and on pre­
liminary studies on the henodynaimc effects of isometric exercise 
and mental arithmetic, the latter two types of stressors were 
selected for application on larger scale in chronically beta-
blocker treated hypertensive patients (chapter VII В). Isometric 
exercise (handgrip) and mental arithmetic were selected for this 
purpose because they represent mechanisms often occurring in 
daily life and because they appeared to induce an appreciable 
increase m forearm blood flow, resembling the effect of an 
adrenaline infusion. 
In this chapter, we present some pilot studies on handgrip 
and mental arithmetic tests, particularly concerning the varia­
bility of the effects on hemodynamics and plasma catecholamines. 
METHODS 
These studies were carried out in normotensive volunteers of 
both sexes. 
Isometric exercise was performed at an indicated percentage 
of maximal handgrip force. Earlier, maximal voluntary contraction 
(MVC) of the preferred hand of each subject had been determined. 
Sustained handgrip was performed with a calibrated strain gauge 
dynamometer, which could be adjusted to fit the subjects hand­
grip. The force was measured with a transducer, a steel ring 
supplied with strain gauges. The force was transduced to a re­
corder in front of the subject. The subjects were asked to hold 
the force constantly at an indicated line corresponding to 15%, 
30% or 50% MVC. They were instructed not to hold their breath 
and were observed for signs of hyperventilation. 
Mental arithmetic was performed by subtracting as fast as 
possible the number 17 from a four-digit number during 5 minutes, 
while a metronome was speeding the subject. The subjects perfor­
med the calculations aloud and were corrected for mistakes. 
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Hemodynamic parameters 
We determined the following hemodynamic parameters: blood 
pressure (BP), heart rate (HR) and forearm blood flow (FBF). 
BP was measured with an Arteriosonde (1225). Mean arterial pres­
sure (MAP) is the sum of the diastolic and 1/3 of the pulse 
pressure. HR was determined by ECG and FBF by strain-gauge ve­
nous occlusion plethysmography (1). In order to achieve a mini­
mal skin blood flow, room temperature was held constantly low 
at 19 0C. Consequently the FBF, measured at this temperature, 
mainly represents muscle blood flow. Figure 1 shows original 
recordings of FBF. Each FBF measurement presented (see results) 
is the mean of at least 2, but mostly 3-5 curves. 
1 % 
/v) U 
F l o w registration 
F _ s t g a 
с 
F = flow (ml / 100ml. min) 
S = paper speed (100 m m / m i n ) 
C=1% calibration ( m m ) 
10 sec 
F 2.0 2 . 6 1 9 6 . 6 6.3 5.A 
Figure 1. Three successive curves of forearm blood flow (FBF) 
before and three curves during mental arithmetic, 
measured with strain-gauge venous occlusion plethys­
mography . 
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Figure 2. Ä recording of exerted handgrip force at 
3 maximal voluntary contractions (MVC) 
followed by 30% MVC during 3 minutes. 
Ikgf = 9.8N 
Catecholamines 
In 8 normotensive subjects, 30 minutes before the test a 
catheter was inserted in an antecubital vein. Immediately be-
fore and at the end of both tests, blood was sampled for deter-
mination of plasma catecholamines. Catecholamines were measured 
by a radio-enzymatic assay (2). 
Statistics 
Statistical analysis was done by Student's t-test for 
paired observations. A p-value of 0.05 was considered as the 
level of statistical significance. Correlation coefficients (r) 
were computed according to Pearson. Variability is presented 
by means of scatter diagrams, demonstrating individual hemody-
namic changes induced by the tests on two different occasions. 
Standard errors of a single observation indicate the reprodu-
cibility of the tests. They were calculated with the formula: 
J ¿ d i 2 
s =
 V —2ΪΓ 
s = standard error of a single observation 
d1= difference between first and second 
test of subject ι 
η = number of paired observations 
Plasma adrenaline and noradrenaline levels before and at the 
end of the tests were compared with Wilcoxon's signed rank test. 
P-values of less than 0.05 were considered to be significant. 
NS means not significant. Results of catecholamines are given 
as mean ± SEM. 
RESULTS 
Handgrip exercise 
The handgrip test consisted of exercising during 3 minutes 
at 30% of the maximal voluntary contraction (MVC) for that 
particular subject (figure 2) . 
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This type of isometric exercise causes considerable rises in blood 
pressure and heart rate (3). These rises are dependent on the per­
centage of MVC that is exerted (figure 3). 
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IX 
ι 
< oJ 
H a n d g r i p 
50% 30% 15% MVC 
ο ι 
Time (min) 
Figure 3. Changes (Δ) in mean arterial pressure (MAP) 
and heart rate (HR) in one subject, exerting 
handgrip at 3 percentages of maximal volun­
tary contraction (MVC) . 
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During handgrip there is a large rise in FBF in the active 
forearm (3) and a small rise in the non-active forearm (figure 
4) . Due to artifacts, it is difficult to measure FBF with a 
Plethysmographie method in the contracting arm. No relation 
was found between the exerted percentage of MVC and the changes 
in FBF in the non-active arm. 
FBF 
(ml/100ml. min) 
30 
25 
20-
15 
s 
10 
8-
0J 
Handgrip 
(30 % MVC) 
\ 
contracting arm 
• non-active arm 
1 
9 
Time (min) 
Figure 4. A representative example of the effect of handgrip 
on forearm blood flow (FBF). In the contracting fore-
arm FBF was measured before and after the test, in the 
non-active forearm before, during and after the test. 
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Figure 5. Scatter diagram of individual changes (Δ%) in mean 
arterial pressure (MAP) induced by handgrip exercise 
in two separate tests in 14 normotensives. Closed sym­
bols represent 30% and open symbols 50% of maximal 
voluntary contraction. Hatched lines indicate a 10% 
difference from the line of identity. 
105 
Δ H R (%) (second test) , 
Α 5 η 
ΑΟ-
3 5 -
3 0 -
2 5 -
2 0 -
1 5 -
10-
5 -
./ 
Handgrip 
о 
/ у 
/ s / / 
' ' S / 
/ / / 
' S / 
' S ' / S ' 
, ' /° ' ' 
' s '' 
/ S / 
• , ' / V ' 
• ' / ' 
' / /' 
,' S / 
' S ' 
• / S,' 
' S ' ' 
s ' · /S/ · //'' ns12 
/Z' r= 0.77 
Ô?— ρ < 0.01 
/ y= 1.08X+1 17 
1 1 1 1 \ 1 1 
-5 / 0 10 15 20 2 5 30 35 
A H R (%) (first test) 
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tested two times. Hatched lines indicate a 
10% difference from the line of identity. 
Figure 5, 6 and 7 show the individual percentual changes (Δ%) 
in MAP, HR and FBF, in the non-active arm, induced by handgrip 
exertion on two separate days. No significant differences were 
found in repetition of the tests, in other words no habituation 
to the tests occurs when handgrip exercise is performed two 
times. The mean percentual changes induced by handgrip exercise 
during the first and second test in the whole group were for 
MAP 23.3% and 23.6%, for HR 12.3% and 14.4% and for FBF 45,2% 
and 45.4% respectively. The standard errors of a single obser­
vation (s) were 3.9%, 5.4% and 27.8% respectively. The corre­
lations between the values of first and second tests were high­
ly significant. Nevertheless, these figures clearly show the 
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considerable intra- and inter-individual varations, most 
striking for FBF. 
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Figure 8. Averaged hemodynamic results in 22 hypertensive 
patients before, during and after 3 min handgrip 
exertion at 30% maximal voluntary contraction (MVC) 
during two placebo periods. 
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Figure 8 shows mean results for BP, HR and FBF, in the non-
active arm, in 22 hypertensive patients during 30% MVC handgrip 
in both placebo periods of the trial that will be described in 
chapter VII В. In fact these periods represent the second and 
fourth performance of the handgrip test in these patients. The 
data show that despite the large individual variation, as men­
tioned earlier, mean effects during the two handgrip tests are 
quite similar. We found no significant differences in hemodyna­
mic changes induced by the test between the two placebo periods, 
except for HR, which increased significantly less during the 
last placebo period. 
Handgrip exercise caused a significant increase in both 
plasma adrenaline and noradrenaline. Before the test plasma adre­
naline was 0.15 ± 0.04 nmol/1, at the end of the test (30% MVC 
for 3 minutes) 0.29 + 0.07 nmol/1 (p < 0.01). Plasma noradrena­
line rose fron 1.20 ± 0.21 nmol/1 to 1.76 ± 0.22 nmol/1 (p < 
0.01) . 
Mental arithmetic 
The standardized mental arithmetic test induced considerable 
increases in blood pressure, heart rate and forearm blood flow. 
The individual percentual changes of these variables caused by 
this test on two separate days in a group of healthy subjects 
are shown in figures 9, 10 and 11. No significant differences 
were found on repetition of the tests, thus habituation to the 
test does not seem to occur. The mean percentual changes induced 
by mental arithmetic during the first and second test in the 
whole group were for MAP 9.8% and 10.9%, for HR 12.1% and 10.8% 
and for FBF 60.6% and 62.1%. The standard errors of a single ob­
servation (s) were 3.0%, 2.6% and 27.1% respectively. These 
figures again demonstrate,as in the handgrip test, highly signi­
ficant correlations and large intra- and inter-individual 
variations, especially marked for FBF. 
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Figure 12. Averaged hemodynamic results in 22 
hypertensive patients before, during 
and after 5 min mental arithmetic 
during two placebo periods. 
Figure 12 gives the mean results of hemodynamics in the 22 
hypertensive patients during the two placebo periods (see pre-
ceding paragraph). There were no significant differences in 
hemodynamic changes induced by mental arithmetic, except for 
FBF, which rose significantly less in the last placebo period. 
Mental arithmetic caused only a significant rise in plasma 
adrenaline, from 0.15 ± 0.03 nmol/1 to 0.22 ± 0.02 nmol/1 
(p < 0.01). Plasma noradrenaline did not change; before the test 
1.49 ± 0.20 nmol/1, at the end of the test 1.41 ± 0.07 nmol/1 
(NS) . 
CONCLUSIONS 
Hangrip exercise and mental arithmetic induce appreciable 
rises in blood pressure, heart rate and forearm blood flow in 
normal subjects. To both tests habituation does not seem to 
occur. The hemodynamic changes show large intra- and inter-
individual variations, most pronounced for FBF. Because of the 
moderate intra-individual reproducibility of these changes 
rather large groups of subjects have to be studied, when the 
influences of drugs on the effects of the tests are to be eva-
luated in a cross-over trial. 
The findings of the changes in plasma catecholamines in-
duced by the tests are in accordance with the literature (4, 
5, 6) and demonstrate that both forms of stress are accompanied 
by a significant rise in plasma adrenaline, on the average 
93% for handgrip and 47% for mental arithmetic. Moreover, during 
handgrip exercise also plasma noradrenaline rises significant-
ly with 47%. 
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SUMMARY 
Hypertensive patients show an unfavourable pressor response to 
exogenous epinephrine during non-selective beta-blockade. In order 
to examine the clinical relevance of this phenomenon, we studied 
hemodynamics during handgrip exercise and mental arithmetic in-
duced epinephrine release. Twenty-two hypertensive patients (14 
men, 8 women) were studied in a double blind cross-over design on 
chronic therapy: placebo, propranolol 240 mg daily and metoprolol 
300 mg daily. Isometric exercise was performed for 3 minutes at 
30% of maximal handgrip force. Mental artihmetic was done for 5 
minutes. Blood pressure, heart rate and forearm blood flow were 
measured before, during and after the tests. Both beta-blockers 
reduced basal values of blood pressure (7-9%) and heart rate (22%) 
as compared to placebo. Changes induced by both stress tests for 
systolic and diastolic blood pressure, heart rate and forearm 
blood flow were similar on both beta-blockers. Rises in heart 
rate and forearm blood flow were equally reduced by both drugs 
compared to placebo. In conclusion, neither handgrip exercise nor 
mental artihmetic revealed significant differences in reaction 
during selective and non-selective oeta-blockade respectively. 
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INTRODUCTION 
Beta-adrenoreceptor blocking drugs are effective antihyper-
tensive agents, which have greatly improved patients comfort 
during therapy. In adequate dosage, beta-^-selective and non-selec-
tive beta-blocking drugs have a similar antihypertensive effect. 
However, stressful conditions, in which epinephrine is released, 
could be expected to induce a stronger rise in blood pressure 
(BP) during non-selective beta-blockade than during selective 
blockade. Infusions of epinephrine caused an increase in diasto-
lic blood pressure (DBP) in patients treated with the non-selec-
tive beta-blocker propranolol, but not when those patients were 
treated with the beta-^-selective blocker metoprolol (13, 16, 17). 
The differences in interaction with epinephrine between the two 
types of beta-blockers were described to the stronger blockade 
of vasodilator beta2-receptors by propranolol than by metoprolol. 
However, epinephrine infusion may not be simply put on a level 
with stress. Isometric exercise and mental arithmetic take common 
place in daily life and both cause an increase in plasma epine-
phrine (20, 4). Moreover, both stresses are accompanied by vaso-
dilation in non-active muscles of the forearm (8, 5). In these 
respects mental artihmetic and isometric exercise resemble epi-
nephrine infusion. 
We examined the influence of selective and non-selective beta-
blockade on the cardiovascular response to the stresses of mental 
arithmetic and isometric exercise in a double blind cross-over 
study in hypertensive patients. Only non-mvasive methods were 
used to avoid other stressful stimuli. 
PATIENTS AND METHODS 
Twenty-five patients gave their informed consent to the study. 
At the start of the trial all patients had stopped their anti-
hypertensive medication for at least four weeks. Three patients 
did not finish the trial (see results). The clinical data of the 
other 22 patients are shown on table I. All patients, but one 
had essential hypertension. One patient had polycystic kidney 
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disease. No patient showed signs of organ damage. 
Table I. Clinical data of the hypertensive patients 
number 22 
male/female 14/8 
age (years) 30.4 (15-54) * 
body weight (kg) 73.4 (55.2-95.4)* 
blood pressure 148/101** 
135-173/90-122* 
141/94*** 
118-157/78-117* 
* range 
** mean of measurements (sphygmomanometer) at the 
last 3 visits to the outpatient clinic before 
therapy was started 
*** mean of measurements (Artenosonde) during the 
training session (cuff about 10 cm above heart 
level) 
Study design 
In a double blind cross-over trial the effects of the non-
selective beta-blocker propranolol and the beta,-selective blocker 
metoprolol and placebo were compared. There were four consecutive 
periods of medication each lasting 4 weeks: placebo I, beta-
blocker, placebo II, beta-blocker. The second placebo period was 
added as a wash-out period. Tablets containing propranolol 80 mg 
and metoprolol 100 mg and placebo were identical in appearance 
and were given three times daily. These doses are considered to 
be equipotent (2). Every two weeks the patients attended the 
clinic for measurement of blood pressure and heart rate (HR) 
and were questioned about intake of drugs and adverse reactions. 
The experiments with isometric exercise and with mental arithme-
tic were performed in one session at the end of each four-week 
period. The order in which both tests were done was randomized 
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on the first occasion and subsequently kept constant in each pa-
tient. The tests were carried out 2-3 hours after ingestion of 
the last tablet. The patients were asked to refrain from coffee 
and smoking during 12 hours before the investigations. Prior to 
the trial, all subjects had been made familiar with the experi-
ments in a training session. 
Test protocol 
Isometric exercise 
After 15 minutes rest in supine position basal measurements 
were started. BP, HR and forearm blood flow (FBF) were measured 
three times. Each FBF measurement consisted of three registra-
tions at the non-dominating forearm. Handgrip exercise was per-
formed for 3 minutes at 30% of maximal voluntary contraction 
(MVC). At the training session maximal voluntary contraction of 
the preferred hand of each patient had been determined. 
The handgrip procedure has been described in detail m chapter 
VII A. The electrocardiogram was monitored throughout the hand-
grip procedure, BP and HR were measured two times, namely 2 
minutes after starting 30% MVC and during the final 45 seconds 
of the test period. BP was measured at the non-exercismg arm. 
In this arm also FBF was measured five times during the test, 
each measurement now consisting of two registrations. This arm 
was elevated obliquely with an arm support with the hand about 
10 cm above heart level. After the test the same measurements as 
before the experiments were repeated. 
Mental arithmetic 
Following 15 minutes of rest basal BP, HR and FBF again were 
measured at the non-dominating arm. Mental arithmetic was per-
formed by subtracting as fast as possible the number 17 from a 
four-digit number during 5 minutes, while a metronome was speeding 
the patient (5). The patients performed the calculations aloud 
and were corrected for mistakes. During the test BP and HR were 
recorded three times, after 1 and 3 minutes and during the final 
45 seconds. FBF was measured 7 times during the test, each measure-
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ment consisting of two curves. After the test similar measurements 
as before were repeated. 
Miscellaneous methods 
Drug intake was checked by counting the remaining tablets after 
each period. During both beta-blocker periods before starting the 
tests blood was drawn for determination of the level of the beta-
blocker. The plasma levels of the drugs were estimated using a 
gas chromatographic method (11). The samples had been stored at 
-20oC until analysis. 
BP was recorded semi-automatically with the Artenosonde 1225. 
Mean arterial pressure (MAP) was calculated as the sum of the 
diastolic and 1/3 of the pulse pressure. HR was measured by ECG, 
using three chest leads. FBF was measured by means of a mercury 
strain-gauge venous occlusion Plethysmograph. Room temperature 
was held constantly low at 19 C, consequently skin blood flow was 
minimal and FBF measured mainly was skeletal blood flow. 
Statistical analysis 
Data of each test and each hemodynamic variable were analysed 
with analysis-of-variance, using a (complete) linear model in-
cluding the (fixed) factors sex, order of medication (propranolol-
metroprolol or vice-versa), patients (nested within the former 
two), situation (before or during test for each of the 4 treat-
ment periods) and all their interactions. All measurements before 
and during the test were used. Estimates of the 8 main effects of 
the factor situation (i.e. means, computed by averaging over the 
levels of the other factors) and of contrasts between these main 
effects with their standard errors, were computed accordingly. 
In comparisons between placebo and beta-blockers, always the first 
placebo period was used. Hypotheses were tested using F-tests and 
t-tests within the model. Plasma levels of the beta-blockers were 
compared with the Student-t-test for period observations. P-values 
of less than 5% were considered to be significant. 
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RESULTS 
Three patients did not finish the trial. One due to domestic 
stress, one because of poor compliance and one because of skin rash 
on metoprolol. The other side effects, which also occurred in the 
placebo periods were of little importance and had no therapeutic 
consequences. The results in the other 22 patients will be con-
sidered. Compliance was good as appeared from the percentage of 
drug ingestion. This percentage amounted to over 92% on all 
occasions. Plasma levels of both beta-blockers were well compara-
ble: on propranolol 408.4 + 56.9 nmol/1 (mean + SEM, range 125-
1170), on metoprolol 509.6 + 56.6 nmol/1 (mean + SEM, range 59-
1110) . 
Isometric exercise 
In figure 1 the mean values of the hemodynamic parameters in 
all patients are depicted from minute to minute. All parameters 
increased during the test as well on placebo as on the beta-
blockers. The time-course during the test shows a continuous rise 
of BP and FBF, whereas HR becomes stable. After the test in a few 
minutes BP and HR reached basal values, FBF almost normalized. 
Table II presents hemodynamic effects in all treatment periods 
before and during handgrip exercise. The data of both placebo 
periods were essentially similar. 
Both beta-blockers equally reduced basal BP (7-9%) and HR (22%). 
Differences m basal values recorded during both treatment 
periods were very small. 
In figure 2 changes in relation to the initial values are given. 
These changes induced by handgrip exercise are compared with each 
other during the different treatment periods. The rise m systo-
lic blood pressure (SBP) and diastolic blood pressure (DBP) on 
placebo was smaller than on beta-blockers (p < 0.01). The increase 
m HR and FBF, however, was greater during the placebo period than 
during both beta-blocker periods (p < 0.01). The increase of the 
respective hemodynamic parameters on placebo numbered (main 
effects + SE): SBP 9.4 + 0.8 mmHg, DBP 12.6 + 0.9 mmHg, HR 6.6 + 
0.6 b/min, FBF 0.92 + 0.08 ml/100 ml.min (an increase of about 
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Figure 1. Averaged hemodynamic results in the 22 hypert-ensive 
patients on placebo I, propranolol and metoprolol 
before, during and after 3 min handgrip exercise at 
30% maximal voluntary contraction (MVC). 
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Table i l Hemodynamics ( e s t i m a t e s of mam e f f e c t s abd SE) of 22 h y p e r t e n s i v e s be fo re (b) 
and d u r i n g (d) t h e handgr ip t e s t in t h e r e s p e c t i v e t r e a t m e n t p e r i o d s (see 
t e x t fo r t he o r d e r of e x p e r i m e n t s ) . 
SBP 
(mn Hg) 
DBP 
(imi Hg) 
MAP 
(mn Hg) 
HR 
(beats/min) 
FBF 
(ml/100 ml.mm) 
placebo 
b 
136.3 
0.5 
91.1 
0.5 
106.2 
0.4 
69.8 
0.3 
3.7 
0.1 
I 
d 
145.7 
0.6 
103.6 
0.7 
117.7 
0.5 
76.3 
0.5 
4.6 
0.1 
placebo 
b 
137.2 
0.5 
92.3 
0.5 
107.3 
0.4 
67.8 
0.3 
3.0 
0.1 
II 
d 
147.1 
0.6 
106.4 
0.7 
120.0 
0.5 
72.4 
0.5 
3.9 
0.1 
propranolol 
b 
127.1 
0.5 
84.2 
0.5 
98.5 
0.4 
55.0 
0.3 
2.7 
0.1 
d 
139.8 
0.6 
100.1 
0.7 
113.4 
0.5 
58.6 
0.5 
3.0 
0.1 
metoprolol 
b 
125.0 
0.5 
81.4 
0.5 
95.9 
0.4 
54.0 
0.3 
3.0 
0.1 
d 
137.1 
0.6 
98.6 
0.7 
111.4 
0.5 
57.4 
0.5 
3.5 
0.1 
SBP = s y s t o l i c p r e s s u r e , DBP = d i a s t o l i c p r e s s u r e , MAP = mean a r t e r i a l p r e s s u r e , HR = h e a r t r a t e , 
FBF = forearm blood flow. 
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Figure 2. Changes (main effects and SE) from basal values in 
blood pressure, heart rate and forearm blood flow 
during handgrip exercise in the 22 hypertensive 
patients on placebo I, propranolol and metoprolol 
** ρ < 0.01. 
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30% for FBF). From the same figure it is clear that the changes 
induced by handgrip exercise during treatment with propranolol 
and during treatment with metoprolol are not significantly dif-
ferent. 
Mental arithmetic 
Figure 3 shows the averaged values of the hemodynamic para-
meters in all patients from minute to minute. The time-course of 
the parameters was essentially similar during the various treat-
ments. After the first minute BP became stable, whereas HR and 
FBF tended to decline. After the test BP came down slowly and 
reached initial values within 15 minutes, whereas HR and FBF fell 
immediately. 
In table III hemodynamic effects in all treatment periods be-
fore and during mental arithmetic are presented. Initial values 
before the mental arithmetic test were not essentially different 
from results obtained before the handgrip test. The data of both 
placebo periods were almost similar. 
In figure 4 changes in relation to the initial values are given. 
On placebo the changes in SBP and DBP were not different from 
changes on both beta-blockers. The increase in HR and FBF was 
significantly smaller on beta-blockade than on placebo (p 0.01). 
The rise of the various hemodynamic variables induced by mental 
arithmetic on placebo numbered (main effects + SE): SBP 8.2 + 0.6 
mmHg, DBP 9.0 + 0.7 mmHg, HR 7.5 + 0.6 b/min and FBF 2.61 + 0.10 
ml/100 ml.min, which was almost a doubling of the initial value 
for FBF. Figure 4 also demonstrates that the changes induced by 
mental arithmetic during treatment with metoorolol and durna 
treatment with propranolol were not significantly different. 
DISCUSSION 
In this study isometric exercise and mental arithmetic were 
used as models for daily life stress. Both tests were performed 
after chronic treatment with propranolol and metoprolol. As medi-
cation schedule we used a cross-over design. Such a design seems 
logical, because carry-over effects of the beta-blockers have 
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Figure 3. Averaged hemodynamic results in the 22 hypertensive 
patients on placebo I, propranolol and metoprolol 
before, during and after 5 min mental arithmetic. 
Table I I I Hemodynamics ( e s t i m a t e s of mam e f f e c t s and SE) of 22 h y p e r t e n s i v e s be fo re (b) 
and dur ing (d) t he menta l a r i t h m e t i c t e s t in t he r e s p e c t i v e t r e a t m e n t p e r i o d s 
(see t e x t fo r t he o r d e r of expe r imen t s ) . 
SBP 
(mm Hg) 
DBP 
(mm Hg) 
MAP 
(im Hg) 
HR 
( b e a t s / m m ) 
FBF 
(ml .100 ml .min) 
p l a c e b o 
b 
135 .8 
0 .4 
9 0 . 6 
0 . 5 
105 .6 
0 . 3 
7 0 . 9 
0 .4 
3 . 7 
0 .1 
I 
d 
144 .0 
0 . 5 
9 9 . 6 
0 .6 
114.4 
0 .4 
78 .4 
0 .4 
6 . 3 
0 .1 
p l a c e b o 
b 
135 .5 
0 .4 
9 1 . 1 
0 . 5 
105 .8 
0 . 3 
6 6 . 7 
0 .4 
3 .4 
0 .1 
I I 
d 
142 .9 
0 . 5 
100.4 
0 . 6 
114 .6 
0 .4 
7 3 . 0 
0 .4 
5 .1 
0 .1 
p r o p r a n o l o l 
b 
126 .3 
0 .4 
8 3 . 9 
0 . 5 
9 8 . 0 
0 . 3 
54 .1 
0 .4 
2 . 9 
0 .1 
d 
135 .2 
0 . 5 
9 3 . 4 
0 . 6 
107 .3 
0 .4 
5 8 . 6 
0 . 4 
3 . 8 
0 .1 
m e t o p r o l o l 
b 
124.4 
0 .4 
8 1 . 6 
0 . 5 
9 5 . 9 
0 . 3 
5 4 . 3 
0 .4 
3 .0 
0 .1 
d 
133.3 
0 . 5 
9 1 . 6 
0 . 6 
105.4 
0 .4 
5 8 . 3 
0 .4 
3 . 8 
0 .1 
SBP = s y s t o l i c p r e s s u r e , DBP = d i a s t o l i c p r e s s u r e , MAP = mean a r t e r i a l p r e s su re , HR = h e a r t r a t e , 
FBF = forearm blood flow. 
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blood pressure, heart rate and forearm blood flow 
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been excluded, due to addition of a placebo period between the 
beta-blocker periods. Moreover, in pilot studies (chapter VII A) 
a large mter-individual variation in the test results had been 
found. Further, in the same pilot experiments we have observed 
a sizable intra-individual variability, therefore in this trial 
a rather large number of patients had to be included. 
At rest both beta-blockers gave a similar fall of BP and HR 
compared to placebo. These findings are in agreement with the 
literature (14). It should be noted that the blood pressures 
listed during the trial were lower than those obtained by con-
ventional sphygmomanometry, both because of the elevated position 
of the arm and because Artenosonde was used. 
Isometric exercise 
The time-course of all determined hemodynamic parameters during 
handgrip exercise is in accordance with the literature (21, 8). 
These circulatory responses are mediated by several mechanisms 
leading to vagal withdrawal and sympatho-adrenal activation with 
sizable effects on heart rate, cardiac output and blood pressure 
and small effects on peripheral resistance (18). The primary sti-
muli causing these hemodynamic changes originate in the con-
tracting skeletal muscles and in higher brain centers (33). 
In earlier studies (13, 16, 17) it was shown that the infusion 
of epinephrine induces vasoconstriction and a considerable rise 
in BP in hypertensive patients, when they are treated with the 
non-selective beta-blocker propranolol. During treatment with the 
beta,-selective blocker metoprolol the normal reaction to epi-
nephrine was largely maintained as appeared from an increase in 
FBF. There are some indications that untoward rises in BP may 
occur during treatment with non-selective beta-blockers, probably 
due to stress-induced release of epinephrine (34, 3, 28). In con-
trast to the effect of epinephrine infusion, however, we did not 
find a difference in the effects due to handgrip exercise in 
hypertensive patients on chronic therapy with propranolol and 
metoprolol respectively. The failure of propranolol to affect the 
BP response to isometric exercise suggests that the hemodynamic 
reaction was not due to increased circulating epinephrine, which 
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has been shown to raise DBP in the presence of non-selective beta-
receptor blockade. Further, the time-course of FBF rise does not 
fit in with epinephrine release, since this rise occurred imme-
diately (within 30 sec) after the start of the test, before a 
rise of the epinephrine level could be expected (20). Moreover, 
in a study of normotensive subjects we found that handgrip exer-
cise increased epinephrine with only 93% (chapter VII A). 
Recently we found that an increase m plasma epinephrine of at 
least 200 to 400% has to occur, before substantial differences 
in reactions to epinephrine between propranolol and metoprolol 
treated subjects can be seen (17). The lack of difference between 
the hemodynamic responses during propranolol and metoprolol treat-
ment in the present study might be explained by assuming that the 
dose of metoprolol was too high to be really beta^-selective. Never-
theless, in our previous studies (13, 16, 17) showing clear dif-
ferences between propranolol and metoprolol treatment the same 
or even higher doses of metoprolol were used. 
Our results are m accordance with some studies of handgrip 
exercise comparing beta^-selective and non-selective blockade (22, 
25, 26, ¿4). Other reports show less rise in BP after beta^-
selective blockade than after non-selective beta-blockade (31, 
37, 35). However, these studies were performed after acute ad-
ministration of the beta-blocker (31), or showed only very small 
differences in BP (37, 35). 
An interesting difference was found in the effect of isometric 
exercise between the placebo period and the beta-blockade period. 
The rise in MAP was significantly greater (4 mmHg) on both beta-
blockers in comparison to placebo. This finding is known in the 
literature (29, 23), but a good explanation is missing. 
Mental arithmetic 
The hemodynamic changes during mental arithmetic are different 
from those during isometric exercise. SBP, DBP, HR and FBF tend 
to attain a plateau after the first minute of the test. Hemo-
dynamic changes are caused by stimulation of the corticohypo-
thalamic brain centers (32), resulting among other things in 
an increased sympatho-adrenal activity. 
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In our study the rises m BP induced by mental arithmetic on 
placebo and on beta-blockade did not significantly differ. These 
findings again contrast with the epinephrine infusion experiments 
(13, 16, 17). The same arguments can be applied as those used in 
the discussion of the handgrip test. In addition, in pilot stu-
dies mental arithmetic caused a rise in plasma epinephrine of 
only 47% (chapter VII A). Data in the literature on BP changes 
during mild mental stress with and without beta-blockade are 
limited and not easy to interpret. Some studies show small dif-
ferences in BP rise during mental stress (37, 4, 7), other inves-
tigators found no differences at all (27, 36, 12). 
Regarding the physiological mechanism of vasodilation in the 
forearm induced by handgrip exercise and mental arithmetic, we 
will make the following speculations. 
It now is generally accepted that FBF - in the non-active 
forearm - increases during handgrip exercise. However, the dis-
cussion continues about explanations of this vasodilation (33). 
One of the hypotheses includes nervously mediated vasodilation, 
either by activation of beta2-receptors in the forearm or by 
sympathetic cholinergic fibers (8, 30). 
As to the mental arithmetic test possible mechanisms of the 
increase in FBF are beta-adrenergic stimulation (10, 19) and sym-
pathetic cholinergic vasodilation (9, 1). As mentioned earlier 
the time-course m the initial phase of both stress tests con-
fers no role for epinephrine release. Nevertheless, the time-
course could fit in with sympathetic neural activity. Moderate 
noradrenaline release (at the neuro-effector-junction) may cause 
beta2-receptor mediated vasodilation (6). 
Our results suggest that the rise in FBF during handgrip exer-
cise and mental arithmetic, at least in part, is beta·)-adrenergic-
receptor mediated, since in both tests the increase in FBF is less 
on beta-blockade than on placebo. However, neurogenic vasodila-
tion in skeletal muscles is linked solely to beta2-receptors 
(15). Nevertheless, in our study the beta., -selective and the non-
selective beta-blocker both equally attenuated the rise in FBF. 
Another possible explanation cannot be ruled out, namely a role 
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of increased alpha-receptor stimulation during treatment with 
beta-blocking drugs. 
Recently it has been suggested that the rise in FBF during 
handgrip exercise and mental stress both may be mediated by 
mental effort (30). Moreover, according to these authors (30) 
this increase in FBF should be a local phenomenon without con-
comitant vasodilation in other skeletal muscles. Our study may 
also support this concept, because when the rise in FBF should 
reflect a systemic vasodilation, the test with the smallest 
increase in FBF should show the greatest increase in BP. How-
ever, in our study the rise in FBF was reduced stronger during 
mental arithmetic, while on the other hand the rise in BP was 
accentuated during handgrip. These speculations concern compa-
risons in changes induced by both tests between beta-blockade 
and placebo (figures 2 and 4). 
In conclusion from a physiological point of view our study 
suggests that the rise m FBF during handgrip exercise and men-
tal arithmetic may be a local phenomenon, partly beta-receptor 
mediated. 
As far as practical use is concerned, this study does not 
argue in favour for beta-;-selective blockers rather than non-
selective beta-blockers in the treatment of hypertension during 
mild forms of stress. 
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GENERAL DISCUSSION 
In studies of adrenaline-infusion (chapter II and III) we 
found a marked difference in reaction to adrenaline when patients 
were treated with the non-selective beta-blocker propranolol or 
with the beta-j-selective blocker metoprolol. During treatment 
with propranolol adrenaline caused a striking "pressor" res-
ponse: namely a rise in forearm vascular resistance and a rise 
in both systolic and diastolic blood pressure. This can be ex-
plained by the blocking of the vascular beta2-receptors/ while 
the available alpha-receptors are stimulated. During treatment 
with metoprolol the normal reaction to adrenaline was largely 
maintained. 
In order to investigate the clinical significance of this 
phenomenon, we selected for further study during beta-blocker 
treatment some stress-stimuli which appeared to be accompanied 
by a raised adrenergic activity, especially by an increased 
adrenaline release. These stress-stimuli were: exposure to cold 
(chapter IV), the drinking of coffee (chapter V), the smoking 
of cigarettes (chapter VI) and isometric exercise and mental 
arithmetic (chapter VII). The former two of these stressors 
were applied in normal subjects after the acute administration 
of both types of beta-blockers. The latter three were used in 
hypertensive patients during chronic treatment with these agents. 
In none of these stress tests, however, could we produce 
the pressor response during non-selective beta-blockade. 
Figure 1 may explain why we did not find differences in 
haemodynamic reactions in all these conditions of raised adre-
nergic activity when the subjects were treated with either the 
non-selective beta-blocker propranolol or the beta-^-selective 
blocker metoprolol. The rise in plasma adrenaline during the 
various kinds of stress was always less than 200%. We had al-
ready concluded that a rise in plasma adrenaline of at least 
200 - 400% has to occur (chapter III), before substantial dif-
ferences in the reaction to adrenaline may be expected. 
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Figure 1. Percentual changes (Δ%) from basal values in 
plasma adrenaline and noradrenaline induced 
by various stress-stimuli. 
At any rate, our studies have not definitively proved that 
during treatment with non-selective beta-blockers untoward 
"pressor" reactions cannot occur spontaneously. Haemodynamic 
responses might be quite different in relation to strong emo­
tional stimuli. In fact these "pressor" reactions have been 
reported by various authors. However, it is difficult to study 
strong stimuli under controlled conditions. Perhaps further 
information should be obtained by long-term intra-arterial or 
indirect blood pressure monitoring during which haemodynamic 
reactions to incidental emotional trauma could be studied in 
relation to the different beta-blockers. 
Notwithstanding, our studies concerning situations with 
raised adrenergic activity, do not lead to the conclusion that 
beta^-selective blockers should generally be preferred over 
non-selective blockers. 
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ALGEMENE SAMENVATTING 

Bi] de behandeling van hypertensie worden bèta-adrenerge 
receptor-blokkerende stoffen, kortweg bèta-blokkers, reeds lang 
op grote schaal toegepast. De bèta-adrenerge receptoren worden 
onderscheiden in bèta..- en bèta2-receptoren. Er zijn bèta-blok-
kers, die vooral de bèta·]-receptoren blokkeren, de zogenaamde 
bèta-| -selectieve of cardioselectieve blokkers. De overige zijn 
de zogenaamde met-selectieve blokkers, die beide receptoren 
blokkeren. De wijze, waarop deze middelen de bloeddruk verlagen 
is nog steeds niet precies bekend, maar waarschijnlijk speelt 
blokkering van bèta.. -receptoren hierbij een belangrijke rol. 
Het in dit proefschrift beschreven onderzoek betreft vooral de 
vraag of aan de bèta-]-selectieve blokkers de voorkeur gegeven 
moet worden boven de met-selectieve bij de chronische behan-
deling van hypertensie. Uit vroeger onderzoek kwam namelijk de 
mogelijkheid naar voren dat tijdens met-selectieve blokkade 
schadelijke bloeddrukstijgingen zouden kunnen optreden bij ver-
hoogde adrenerge activiteit, met name onder invloed van adre-
naline . 
Om dit te verduidelijken moet eerst een korte uiteenzetting 
worden gegeven over de verdeling van de receptoren en hun ge-
voeligheid voor adrenaline, het stress-hormoon bij uitstek. Hoe-
wel de scheiding van bèta-receptoren in bèta·] en bèta2 niet 
strikt is, aangezien de meeste weefsels beide receptoren bezit-
ten, is voor praktische doeleinden het volgende schema goed 
bruikbaar. Wat betreft het cardiovasculaire systeem zijn in het 
hart overwegend beta., -receptoren aanwezig en bevinden zich in 
de bloedvaten van de skeletspieren voornamelijk bèta^-recepto-
ren, die bij stimulering vaatverwijding (vasodilatatie) geven, 
maar ook alpha-receptoren, die bij stimulering vaatvernauwing 
(vasocontrictie) geven. Adrenaline stimuleert de bètaj-recepto-
ren sterker dan ae bèta-|- en alpha-receptoren. Het netto effect 
van adrenaline is dan ook een vasodilatatie van deze spierbloed-
vaten. Wanneer nu adrenaline werd toegediend tijdens gebruik van 
de met-selectieve bèta-blokker propranolol vonden Johnsson en 
van Herwaarden een toename van de vaatweerstand (vasoconstrictie) 
in de spieren zich uitend in een sterke stijging van zowel sys-
tolische als diastolische bloeddruk, ook wel pressor-reactie 
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genoemd. Bij gebruik van het selectief bèta., -blokkerende meto-
prolol bleef de normale reactie op adrenaline nagenoeg onverlet: 
de vaatweerstand in de spieren daalde (vasodilatatie) en de (ge-
middelde) artenële bloeddruk veranderde niet. Blijkbaar gaat 
tijdens met-selectieve bèta-blokkering het alpha-stimulerende 
effect van adrenaline overwegen, terwijl na toediening van meto-
prolol, adrenaline tot bèta2-stimulatie (en dus tot vasodila-
tatie) in staat blijft. Het is voorstelbaar, dat deze ongewenste 
bloeddrukstijging of pressor-reactie ook voorkomt in andere si-
tuaties van verhoogde adrenerge activiteit. Het dagelijks leven 
kent vele van deze situaties, waarbij via stimulering van het 
bijniermerg adrenalme-uitstorting plaatsvindt. 
Het begrip stress kan in al deze situaties gehanteerd wor-
den. Stress wordt dan uitsluitend gebruikt ter aanduiding van 
stimuli, die tot verhoogde adrenerge activiteit aanleiding ge-
ven. Op de mogelijke verstoring van de normale aanpassing aan 
stress, bijvoorbeeld door het optreden van dergelijke pressor-
reacties, wordt in dit proefschrift nader ingegaan. 
In eerste instantie doet zich de vraag voor of het waarge-
nomen verschil in haemodynamische reactie op adrenaline ook aan-
wezig is, wanneer patiënten naast bèta-blokkerende middelen 
andere antihypertensiva gebruiken. Bij ernstiger hypertensie 
is immers vaak een behandeling met een combinatie van middelen 
nodig. Veelal bestaat een dergelijke combinatie uit een bèta-
blokker, een diureticum en soms nog een vaatverwijder. Diure-
tica en vaatverwijders werken niet via bèta-receptoren. Theo-
retisch laten deze middelen de bèta-receptoren dus ongemoeid. 
Er zijn echter studies, die aantonen dat tijdens behandeling met 
diuretica de gevoeligheid van de bèta-receptoren afneemt. An-
dere studies melden bij infusie van catecholaminen een geringere 
bloeddrukstijging bij gebruik van diuretica en vaatverwijders 
dan zonder deze middelen. 
Wij hebben (hoofdstuk II) adrenaline geinfundeerd bij 25 
patiënten met hypertensie tijdens chronische behandeling met 
zowel propranolol als metoprolol. Twaalf patiënten gebruikten 
een combinatie van bèta-blokkers en diuretica, de andere 13 
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patiënten bovendien nog vaatverwijders. In beide groepen was er 
een evidente pressor-reactie tijdens adrenaline-infusie onder 
propranolol medicatie. Deze ongunstige reactie was afwezig wan-
neer van de combinatie-therapie alleen propranolol was vervan-
gen door metoprolol. Het verschil in de reactie op adrenaline 
tussen patiënten behandeld met propranolol en met metoprolol 
wordt dus niet beïnvloed, wanneer aan de therapie diuretica en 
vaatverwijders zijn toegevoegd. Verder bleek uit deze studie dat 
de selectiviteit van metoprolol afneemt bij hogere plasmaconcen-
traties van het middel. Infusie van adrenaline gaf namelijk een 
grotere stijging van de geiriddelde arteriële bloeddruk bij 
patiënten, die een hogere dosis metoprolol hadden dan bij 
patiënten met een lagere dosis. Een andere bevinding was de zeer 
sterke stijging van het adrenalinegehalte van het plasma bij de ge-
bruikte infusiesnelheid van 8 microgram/minuut. De toename van adre-
naline was bijna 50-voudig. Een dergelijke toename is uitzon-
derlijk voor stress in het dagelijks leven en komt - voor zover 
bekend - slechts voor onder extreme omstandigheden zoals bij 
hypoglycaemie. 
Om stress met een geringere adrenaline-uitstorting te simu-
leren, hebben wij adrenaline in lagere snelheden geïnfundeerd 
tijdens chronische behandeling met eerst de ene bèta-blokker 
en later de andere (hoofdstuk III). Zo werd bij hypertensie-
patiënten tweemaal adrenaline geïnfundeerd met snelheden van 
0.5 - 1.0 - 2.0 - 4.0 microgram/minuut. Ook m deze studie was 
er een duidelijk verschil in de haemodynamische reactie op het 
adrenalme-mfuus tijdens gebruik van de met-selectieve en tij-
dens de selectieve bèta-blokker. Het verschil in reactie was 
reeds aanwezig bij de laagste dosis adrenaline (0,5 microgram/ 
minuut). Tijdens therapie met propranolol veroorzaakte adrena-
line een gemiddelde arteriële bloeddrukstijging van 5%, terwijl 
bij behandeling met metoprolol de bloeddruk niet steeg. Bij nog 
lagere doseringen van adrenaline zijn de haemodynamische ver-
anderingen klinisch niet relevant. Bij de laagste door ons ge-
bruikte infusiesnelheid kan een stijging van het plasma-adre-
naline van 200-400% verwacht worden. 
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Het infunderen van adrenaline blijft echter een kunstmatige 
vorm van stress en niet zonder meer gelijk te stellen met stress, 
die spontaan voorkomt. Lichamelijke inspanning leidt ook tot 
verhoogde adrenerge activiteit en is dus een meer fysiologisch 
voorbeeld van stress. Er zijn 2 vormen van fysieke belasting: 
dynamische en isometrische inspanning. Volgens de meeste schrij-
vers geeft isometrische inspanning een belangrijke verhoging 
van de adrenerge activiteit. Een aantal andere stresses uit het 
dagelijks leven, die niet gepaard gaan met lichamelijke inspan-
ning, geven eveneens een duidelijke adrenaline-uitstortmg. 
Dit zijn stimuli als: mentale belasting, koffie drinken en siga-
retten roken. Volgens sommige auteurs leidt ook koude-provocatie 
tot een verhoging van adrenerge activiteit. Om de klinische 
relevantie van de adrenaline-mfusie experimenten te toetsen, 
onderzochten wij haemodynamische parameters in de genoemde 
situaties van verhoogde adrenerge activiteit. Om zoveel mogelijk 
ongewenste stimuli te vermijden werd gebruik gemaakt van niet-
invasieve meetmethoden. Gemeten werden de bloeddruk met behulp 
van een Artenosonde, de hartf requentie via ECG-af leidingen en 
de spierdoorbloeding van de onderarm (forearm blood flow) mid-
dels veneuze occlusie plethysmografie. Voorts werd voor en na 
de diverse stress-testen bloed afgenomen voor bepaling van de 
catecholaminen in plasma: het hormoon adrenaline en de neuro-
transmitter noradrenaline. De catecholaminen werden bepaald 
met een radio-enzymatische methode. Geruime tijd voor het begin 
van de haemodynamische metingen werd een catheter ingebracht 
voor bloedafname. 
In hoofdstuk IV worden de resultaten beschreven van de zo-
genaamde "cold pressor test". De haemodynamische reactie die 
door deze test wordt veroorzaakt, komt waarschijnlijk tot stand 
via een complex van prikkels als pijn, angst en koude. De koude-
provocatie werd gedaan door onderdompeling van een voet m 
water van 50C gedurende 6 minuten. Zeventien proefpersonen met 
normale bloeddruk ondergingen de test driemaal: éénmaal zonder 
medicatie, éénmaal na 3 χ 80 mg propranolol en éénmaal na 3 χ 
100 mg metoprolol. De testen werden verricht in een door het 
lot bepaalde volgorde. Zonder medicatie veroorzaakte de test 
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een aanzienlijke verhoging van systolische en diastolische 
bloeddruk van gemiddeld respectievelijk 18 en 16 mm Hg. De hart-
frequentie steeg eveneens, de spierdoorbloedmg nam af. De eerste 
2 minuten was de stijging in bloeddruk en hartfreguentie het 
grootst, maar na 6 minuten was nog steeds een stijging aanwezig. 
Beide bèta-blokkers verlaagden in gelijke mate de uitgangswaarden 
van bloeddruk en hartfrequentie en verminderden ook de stijging in 
hartfrequentie tijdens de koude-test. De verandering m bloeddruk 
door koude werd door voorafgaand gebruik van bèta-blokkerende 
middelen niet beïnvloed. De koude-provocatie gaf echter geen 
stijging van het plasma-adrenaline. Wel steeg het plasma-nora-
drenaline met 47%. Dit betekent dat deze vorm van stress wel het 
orthosympathische systeem activeert, maar niet het bijniermerg. 
In hoofdstuk V wordt verslag gedaan van de haemodynamische 
en humorale effecten van het drinken van koffie ббг en na het 
gebruik van bèta -pselectieve en met-selectieve blokkers. Het 
effect van Coffeine op de circulatie is complex. De effecten 
van Coffeine worden enerzijds veroorzaakt door centrale mecha-
nismen als stimulatie van vagale centra en van het vasomotoren-
centrum m de hersenstam, anderzijds via perifere mechanismen. 
Perifeer geeft Coffeine direct een verhoging van het intracellu-
lair cyclisch adenosinemonophosphaat en een toename van de cal-
ciuminflux in de cellen. Indirect zou Coffeine perifeer haemo-
dynamische veranderingen induceren via het renme-angiotensine-
aldosteron systeem en via een verhoging van de plasma-catechol-
ammen.Bij 12 proefpersonen met normale bloeddruk werd na mini-
maal 17 uur onthouding van koffie een kof f lebelastmg uitgevoerd. 
De proefpersonen dronken 300 ml koffie, ongeveer overeenkomend 
met 300-400 mg Coffeine. In een door het lot bepaalde volgorde 
werd de test driemaal uitgevoerd: éénmaal na placebo, éénmaal 
na 3 χ 80 mg propranolol en éénmaal na 3 χ 100 mg metoprolol. 
De meting van de haemodynamische en humorale parameters geschied­
de 60-80 minuten later, op het moment dat de plasmaconcentraties 
van Coffeine maximaal waren. In de placebo-studie resulteerde 
het drinken van koffie in een toename van systolische en dias­
tolische bloeddruk met gemiddeld 5 en 11 mm Hg. De hartfrequen­
tie daalde en de spierdoorbloeding veranderde niet. 
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Het gebruik van bèta-blokkers resulteerde in een verlaging van 
de uitgangswaarden van bloeddruk en hartfrequentie. De veran-
deringen van de hsemodynamische paranieters onder invloed van 
het drinker van koffie waren echter in essentie hetzelfde als 
in de placebo-studie. Koffie drinken leidde tot een verhoging 
van het plasma-adrenaline van gemiddeld 14 7% en van het nor-
adrenalmegehalte van 19%. 
Een andere veel gebruikte stimulus in het dagelijks leven 
is het roken van sigaretten. Ook de werking van dit"genotmiddel" 
op de circulatie is complex. Aangenomen wordt dat nicotine ver-
antwoordelijk is voor de haenodvnamische veranderingen. Deze 
werking verloopt via directe stimulatie van chemoreceptoren, 
voorts via activatie van het parasympathische systeem en ten-
slotte via activatie van het adrenerge systeem, zich uitend in 
een stijging van plasma-catecholaminen. Bij 16 hypertensie-
patiênten hebben wij het haemodynamische effect van sigaretten 
roken onderzocht vóór en na chronische behandeling met bêta,-
selectieve en met-selectieve bèta-blokkers (hoofdstuk VI). 
Het roken van 2 sigaretten (1,5 mg nicotine/sigaret) gaf in de 
3 onderzochte situaties een zelfde verhoging van de bloeddruk. 
In de contrôle-studie steeg de systolische bloeddruk ge-
middeld 8 mm Hg en de diastolische bloeddruk gemiddeld 9 mm Hg. 
De toename van de hartfrequentie werd door beide beta-blokkers 
geremd. Veelal waren 1 uur na beëindiging van de test de haemo-
dynamische parameters nog met teruggekeerd tot de uitgangs-
waarden. In onze studie gaf sigaretten roken geen verhoging 
van het plasma-noradrenalme, wel steeg het plasma-adrenaline 
met gemiddeld 108%. Van praktisch belang lijkt het dat siga-
retten roken en koffie drinken langdurig (tenminste 1-2 uur) 
bloeddrukverhogend kunnen werken. 
In hoofdstuk VII wordt een studie beschreven betreffende 
isometrische spiercontractie (handgrip) en hoofdreken-stress 
(mental arithmetic). Bij isometrische spiercontractie vindt na 
aanspanning van de betreffende spiergroepen geen verdere ver-
korting en dus ook geen beweging meer plaats. Bij tal van acti-
viteiten m het dagelijks leven komt isometrische belasting 
voor. De stimuli, die bij isometrische contractie de haemo-
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dynamische veranderingen veroorzaken, zijn afkomstig uit de 
contraherende spiergroepen en uit hogere hersencentra. Een en 
ander resulteert in onderdrukking van de vagale tonus en in 
een activatie van het adrenerge systeem. De haemodynamische 
respons is grotendeels onafhankelijk van de hoeveelheid contra-
herend spierweefsel, doch wordt bepaald door de relatieve con-
tractiekracht (oftewel het percentage van de maximale contrac-
tie) uitgeoefend door de betreffende spiergroep. In hoofdstuk 
VII A hebben wij enige van deze specifieke haemodynamische 
veranderingen laten zien.Isometrische contractie geeft een toe-
name van zowel systolische als diastolische bloeddruk, dit in 
tegenstelling tot dynamische belasting waarbij wel de systo-
lische bloeddruk stijgt, maar de diastolische bloeddruk meestal 
gelijk blijft of daalt. Tijdens isometrische spiercontractie 
blijft de bloeddruk stijgen totdat de contractie wordt gestaakt. 
De hartfrequentie en de spierdoorbloeding in de onderarm, die 
niet contraheert, nemen duidelijk toe. Er is een tamelijk grote 
intra- en mter-mdividuele variabiliteit van de gemeten haemo-
dynamische veranderingen die optreden tijdens isometrische con-
tractie. Er treedt echter geen gewenning aan de test op. De 
plasma-catecholaminen stijgen aanzienlijk: adrenaline met ge-
middeld 93% en noradrenaline met gemiddeld 47%. 
Hoofdreken-stress (mental arithmetic) kan beschouwd worden 
als een vorm van mentale belasting. De haemodynamische veran-
deringen worden m eerste instantie veroorzaakt door stimulatie 
van de hogere hersencentra. Uiteindelijk wordt ook het adre-
nerge systeem geactiveerd. Zowel de systolische als de dias-
tolische bloeddruk stijgen; na de Ie minuut van de test treedt 
geen verdere stijging van de bloeddruk meer op. Hetzelfde geldt 
voor de hartfrequentie. De spierdoorbloeding van de onderarm 
neemt zeer sterk toe. Ook bij deze test is de intra- en inter-
individuele variabiliteit van de onderzochte parameters tamelijk 
groot. Doch ook deze test lijkt geen gewenning te geven. Mental 
arithmetic geeft een verhoging van het plasma-adrenaline van 
47%, terwijl het plasma-noradrenaline niet verandert. 
Beide vormen van stress, de isometrische spiercontractie 
en de mentale belasting lijken dus m bepaalde opzichten op 
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het "adrenalme-infuus" : het adrenalinegehalte van het plasma 
stijgt en er treedt een duidelijke toename op van de spier-
doorbloeding. Deze tests werden daarom geselecteerd voor een 
uitvoeriger onderzoek bij hypertensie-patiënten. 
Hoofdstuk VII В beschneit deze studie bij 22 hypertensie-
patiënten, die beide testen ondergingen tijdens chronische be-
handeling met propranolol, met metoprolol en tijdens placebo-
medicatie. De studie werd dubbelblind uitgevoerd volgens een 
cross-over model. Er waren 4 opeenvolgende periodes van mini-
maal 1 maand: placebo, bèta-blokker, placebo, bèta-blokker. 
Aan het einde van elke periode werden beide testen uitgevoerd. 
Ten opzichte van de placebo-periode verlaagden de bèta-blokkers 
de bloeddruk nagenoeg gelijk met 8-10 mm Hg en de hartfrequentie 
met bijna 15 slagen per minuut. Isometrische contractie (30% 
van de "maxiral voluntary contraction") gaf tijdens placebo-
medicatie een systolische bloeddrukstijging van gemiddeld 9 mm 
Hg en diastolisch van 13 mm Hg. Tijdens mental arithmetic steeg 
de bloeddruk gemiddeld 8 mm Hg en diastolisch 9 mm Hg. De toename 
in hartfrequentie en in spierdoorbloeding - in de met-actieve 
skeletspieren - was geringer tijdens beide vormen van stress 
bij gebruik van de bèta-blokkers dan bij gebruik van placebo. 
Dit kan betekenen, dat de bèta-receptoren betrokken zijn bij 
de regulatie van de spierdoorbloeding tijdens isometrische in-
spanning en mental arithmetic. De belangrijkste vraagstelling 
van deze studie was echter of er een verschil bestond in haemo-
dynamische reactie op deze twee vormen van stress tijdens ge-
bruik van propranolol enerzijds en metoprolol anderzijds. Wat 
dit betreft kan in deze studie geen significant verschil in 
reactie van de haemodynamische parameters op de stresses worden 
gevonden. Vanuit fysiologisch oogpunt gezien, draagt deze studie 
argumenten aan, dat de veranderingen in spierdoorbloedmg van 
de onderarm m eerste instantie niet worden geïnduceerd door 
adrenalme-uitstorting . 
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Figuur 1. Percentuele veranderingen (Δ%) in 
plasma-adrenaline en plasma-noradre­
naline ten opzichte van de uitgangs­
waarden tijdens diverse stress-stimuli. 
Figuur 1 geeft aan waarom bij alle onderzochte vormen van 
verhoogde adrenerge activiteit of stress geen verschil in haemo-
dynamische reactie werd gevonden, wanneer proefpersonen of 
patiënten hetzij met de niet-selectieve bèta-blokker propranolol, 
hetzij met de bèta1-selectieve blokker metoprolol werden behan-
deld. De verhoging van het plasma-adrenaline in de verschillen-
de vormen van stress was steeds minder dan 200%, de laagste 
waarde waarbij adrenaline (hoofdstuk III) een verschil in 
haemodynamische reactie veroorzaakte. Toch is hiermee niet aan-
getoond dat tijdens behandeling met niet-selectieve bèta-blok-
kers geen ongewenste pressor-reacties kunnen voorkomen. In feite 
zijn deze reacties door meerdere auteurs beschreven. Natuurlijk 
voorkomende stress is echter niet gemakkelijk in een kunstma-
tige proefopstelling te onderzoeken. Uit onze studies aangaande 
situaties met verhoogde adrenerge activiteit valt echter niet 
de conclusie te trekken, dat onder alle omstandigheden aan 
bèta-]-selectieve blokkers de voorkeur moet worden gegeven. 
153 

WOORDEN VAN DANK 
Velen hebben bijgedragen aan het tot stand komen van dit proef-
schrift en hiervoor wil ik hen allen hartelijk dank zeggen. 
Enkelen wil ik hier uitdrukkelijk vermelden, zonder anderen te-
kort te willen doen. Vanzelfsprekend ben ik veel dank verschul-
digd aan de patiënten en proefpersonen, die bereid waren mede 
te werken aan delen van de studie. De testen, die zij ondergin-
gen waren niet altijd even aangenaam. 
De verpleegkundige staf van de gemeenschappelijke polikliniek 
onder leiding van mevr. T.T.M. Hoogenbosch was behulpzaam bij 
het uitvoeren van diverse testen. Bijzonder waardeer ik de tech-
nische assistentie van de heer A.C.A. Vissers van de werkgroep 
inspanningsfysiologie. 
De collegae B.J. Brenninkmeyer, G. Wijnands en P. Smits hebben 
een niet geringe bijdrage aan het onderzoek geleverd m het kader 
van hun wetenschappelijke stage. 
De heren Ir. Th. de Boo en W.A.J. Lemmens van de Mathematisch 
Statistische Adviesafdeling hebben vele uren besteed aan de 
bewerking van de gegevens en voorzagen het onderzotK van kritische 
kanttekeningen. 
De tekeningen van dit proefschrift werden met zorg vervaardigd 
door de heer H.M. Berns van de afdeling Medische Illustratie 
en gefotografeerd door de medewerkers van de afdeling Medische 
Fotografie. 
De staf van de Medische Bibliotheek was behulpzaam bij het ver-
zamelen van de literatuur. 
De diverse versies van hoofdstukken en artikelen werden nauwge-
zet en toegewijd getypt door Mariet Beurskens, Ineke ten Have, 
Angèle Wentholt en Anky Verweijen. Het definitieve manuscript 
werd drukklaar gemaakt door Anky Verweijen. 
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CURRICULUM VITAE 
De schrijver van dit proefschrift werd geboren op 30 december 
1947 te Heerlen. Hij bezocht het Bisschoppelijk College te 
Sittard en behaalde het einddiploma gymnasium β in 1966. Aan­
sluitend studeerde hi;) geneeskunde aan de Rijksuniversiteit te 
Utrecht, waar hxj in 1971 het doctoraalexamen en in 1973 het 
artsexamen aflegde. Vervolgens vervulde hi] als garnizoensarts 
zijn militaire dienstplicht. In 1975 begon zijn opleiding tot 
internist, aanvankelijk in het St. Elisabethziekenhuis te 
Amersfoort (opleider Dr. D. Bonte) en vanaf 1977 aan de Uni­
versiteitskliniek voor Inwendige Ziekten te Nijmegen (destijds 
opleider Prof. Dr. C.L.H. Majoor). In 1979 werd een begin ge­
maakt met het onderzoek dat de basis vormt voor dit proefschrift. 
In mei 1980 werd hij ingeschreven in het specialistenregister. 
Vervolgens was hij werkzaam op de afdeling algemeen interne 
geneeskunde (hoofd Prof. Dr. A. van 't Laar). Momenteel is hij 
werkzaam op de afdeling Reumatologie (hoofd Prof. Dr. L.B.A. 
van de Putte) van de Universiteitskliniek te Nijmegen. 
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STELLINGEN 
1 
Het moeten definiëren van het begrip "stress" kan ongetwijfeld 
worden beschouwd als "stress". 
2 
Tijdens behandeling met met-selectief ß-blokkerende middelen 
kan een betrekkelijk geringe stijging van de plasma-adrenaline-
concentratie (200-400%) tot een ongewenste bloeddrukstijging 
leiden. 
- dit proefschrift 
3 
Een sterke verhoging van de bloeddruk tijdens met-selectieve 
ß-blokkade, zoals wordt veroorzaakt door infusie van adrenaline, 
treedt niet op tijdens isometrische inspanning (handgrip) en 
hoofdrekenen. 
- dit proefschrift 
4 
Sigaretten roken en koffie drinken kunnen langdurig (1-2 uur) 
bloeddrukverhogend werken. 
- dit proefschrift 
5 
Het stellen van de diagnose hypertensie leidt tot verhoogd 
ziekteverzuim. 
- Charlson ME e.a. Am J Med 73: 165 (1982) 
Dit is een reden temeer om de bloeddruk lege artis te meten. 
6 
Peroperatieve EEG-bewaking tijdens carotis-chirurgie is een be­
trouwbare bewakingsmethode, die geen complicaties voorkomt, maar 
deze eerder signaleert en derhalve eerder adequate maatregelen 
oproept. 
Het preoperatief meten van de knijpkracht van de met-dominante 
hand is een gevoelige maat voor het voorspellen van postopera­
tieve complicaties. 
- Klid^ian AM e.a. Br Med J 281: 899 (1980) 
8 
Het roken van sigaretten vertraagt de absorptie van subcutaan 
toegediend insuline. 
- Klemp Ρ e.a. Br Med J 284: 237 (1982) 
Het verdient aanbeveling in het medisch curriculum praktisch 
geneesmiddelonderzoek op te nemen. Een vergelijkend onderzoek 
naar de effecten van koffie en coffeïne-vnje koffie is een 
medisch-ethisch verantwoord model van een dergelijke "trial". 
- Meissner O e.a. A method for demonstrating clinical 
trial principles to medical students. 
S Afr Med J 62: 93 (1982) 
10 
Bij het verrichten van negatieve arbeid kan een groot uitwendig 
vermogen worden geleverd zonder grote belasting van het cardio-
respiratoire systeem. 
- Hulsbosch MAM Proefschrift, Nijmegen (1981) 
11 
Behandeling met goud geeft bi] rokers een significant grotere 
binding van goud aan de erythrocyt dan bij met-rokers. De 
klinische relevantie hiervan bij de behandeling van reumatoïde 
arthritis verdient nader onderzoek. 
- Graham GG e.a. James DW e.a. J Rheumatol 9: 527, 532 (19Θ2) 
12 
Statistisch significant maakt nog niet relevant. 
13 
Als de vrouw en dan de man om beurten een kind ter wereld moes­
ten brengen,zou men er nooit meer dan drie hebben. 
- Anonymus 
Nijmegen, 10 december 1982 H.H.M.L. Houben 



